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ABSTRACT
Dupuytren’s disease is the result of a chronic inflammatory process, producing 
progressive contracture of patients’ fingers. The histology of Dupuytren’s tissue 
has been well studied; demonstrating inflammatory cells in addition to the 
myofibroblasts within the Dupuytren’s nodule itself. These inflammatory cells 
produce growth factors and cytokines that regulate the proliferation and 
progressive contracture of the Dupuytren’s myofibroblasts.
The mechanism of the migration of these inflammatory cells through the 
endothelial walls of the blood vessels within the Dupuytren’s tissue is not well 
established. This work examined one possible pathway of inflammatory cell 
adherence to the endothelial cells and their migration.
The cells in Dupuytren’s tissue expressing the integrin a4p 1 and the 
corresponding ligands, Vascular Cell Adhesion Molecule -  1 (VCAM-1) and 
HepII/IIICS region of fibronectin known as CSl were studied.
Transforming Growth Factor-beta (TGF-beta) is an important group of factors 
linked with fibrosis. The distribution of TGF-beta production in relationship to 
the expression of CSl region of fibronectin was also studied in Dupuytren’s 
tissue.
Cells expressing 1 were noted principally in and around the blood vessels 
expressing VCAM-1 and CSl fibronectin. VCAM-1 was present within the
endothelium of blood vessels surrounding and penetrating areas of active nodule 
growth. TGF-beta was noted to be expressed in very similar areas to the CSl 
sequence of fibronectin.
Having established this, the effect of methylprednisilone steroid injected locally 
around the Dupuytren’s nodule was studied. The effect of steroids on the 
expression of growth factors and pro-inflammatoiy cytokines (Interleukin-1 (IL- 
1), Interleukin-4 (IL-4), Interleukin -6  (IL-6), Interleukin-8 (IL-8), Tumour 
Necrosis Factor-alpha (TNF-alpha) and TGF-beta was investigated. In addition, 
the effect of steroids on the presence of the adhesion molecule VCAM-1, CSl 
sequence of fibronectin and a4^ 1 expressing cells was studied.
In Dupuytren’s tissue treated with steroid, the studied groAVth factor and cytokine 
expression was reduced, VCAM-1 expression was down regulated in the blood 
vessels, as was CSl fibronectin and the number of a4p 1 expressing cells was 
reduced.
As chronic inflammation may represent a failure of inflammatory cells to 
undergo apoptosis, the rates of apoptosis and proliferation of cells within the 
Dupytren’s nodule was assessed by immunological staining for the Lewis Y 
marker and the Ki67 antigen respectively.
In addition, cells fi-om Dupuytren’s nodules were cultured and studied using flow 
cytometry measurements of cellular markers of apoptosis (Annexin V binding). 
This was compared to fibroblast cultures fi*om specimens of palmar fascia taken
at carpal tunnel decompression, where Dupuytren’s disease was not present. 
Fibroblasts were also cultured from specimens of fascia lata taken at hip surgery. 
These fibroblasts acted as controls. The effect of addition of steroid was again 
studied.
Steroid produced a marked increase in cellular apoptosis, as represented by 
Lewis Y marker binding and a reduction in proliferation, as measured by Ki67 
antigen binding. In the cell culture experiments, Dupuytren’s cells were much 
more sensitive to steroid induced apoptosis than fibroblasts from normal carpal 
tunnels.
By understanding the factors involved in controlling inflammatory cell adherence 
and transendothelial migration and the subsequent failure to undergo normal 
apoptosis, therapeutic intervention to prevent progression may be possible.
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Plater’s description of Dupuytren’s contracture,
1614. ’Contraction of the fingers of the left hand into the 
palm. A certain well-known master mason, on tolling a 
large stone, caused the tendons to the ring and little fingers 
in the palm of the left hand to cease to function. They 
contracted and in so doing were loosed from the bonds by 
which they are held and became raised up, as two cords 
forming a ridge under the skin. These two fingers will 
remain contracted and drawn in forever.*
’Translation by J. B. St. Clair, 1987.’ 
(Reproduced by kind permission of the Wellcome 
Institute for the History of Medicine.)
Figure 1
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1.1
HISTORY OF DUPUYTREN'S DISEASE
In 1641 the features of Dupuytren’s disease were first observed and recorded by 
Felix Plater of Basel, Switzerland, in his book ^'Observationum ”, in which he 
discussed the diseases of the body and soul. He described a stone mason who 
developed contractures of the ring and little fingers of his left hand. Plater at the 
time attributed this to tightness of the underlying flexor tendons (Figure 1).
Henry Cline, a pupil of John Hunter, in 1777 was perhaps the first to accurately 
describe the features of idiopathic contracture of the palmar fascia. Sir Astley 
Cooper also published descriptions of the condition in 1822, noting that it arose 
within the aponeurotic layer of the palm. Boyer, 1831, called the contracture 
'crispartura tendinum'. It was not until 1832, that Baron Guilaume Dupuytren 
(1777-1835) delivered his own description of the contracture at his lecture at the 
Hotel-Dieu, Paris. He later wrote, ' La plupart des individus que cette maladie 
affecte, ont été obliges de faire des efforts avec la paume de main et de manier 
des corps durs'. Perhaps due to his flamboyant nature it is his name that is 
associated with the condition. He described and presented several cases of the 
disease, including his own coachman, giving his own opinion of the anatomy. He 
also reviewed unsuccessftil therapeutic regimens, and finally considered the 
results of his own treatment by fasciotomy and splintage. Even immediately after 
this publication by Dupuytren, the condition provoked debate. Jean Goyrand 
contested Dupuytren's assertion of the link to manual labour and cited bilateral
21
disease in his own hospital manager, who had never done a day of hard labour in 
his life (Goyrand, 1833).
Even today the debate over the aetiology, histology, pathogenesis and treatment 
is as hotly contested despite over 160 years of research.
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1.2
ANATOMY
An understanding of Dupuytren's disease is not possible without knowledge of its 
relation to the anatomy of the fascia of the palm and digits.
Fascial anatomy of the hand
One of the first descriptions of palmar fascia was by Vesalius (1514-1564). 
Subsequent work has further delineated the normal anatomy of the fascial 
structures of the hand.
The palmar fascia is a triangular, dense fibrous structure with an apex towards 
the interval between the thenar and hypothenar eminence. Its base is parallel to a 
line joining the metacarpal necks. Proximally it is continuous with the pahnaris 
longus tendon (Absent in 11-23%). Distally it sends slips running centrally and 
laterally to both sides of each digit. The palmar-digital and digital fascia may be 
divided into pretendinous bands, spiral bands, natatory ligaments, Grayson's 
ligaments, Cleland’s ligaments and the lateral digital sheath. (Figure 2)
Together this palmar and digital aponeurosis stabilises the palmar skin during 
gripping actions of the hand, preventing displacement that would occur with 
shear loading of the palmar skin.
In the diseased states of Dupuytren's disease these ligaments, sheaths and bands 
act as guidance paths for the pathological cords of Dupuytren's tissue. Dupuytren
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himself overlooked this as he believed the disease involved only the aponeurosis 
and overlooked the fact that the normal aponeurosis did not extend into the 
fingers v^hich fi’equently contained pathological cords.
The four main named cords are the central cord, the spiral cord, the lateral cord 
and the retrovascular cord (Figure 3). The retrovascular cord is not illustrated. An 
abductor digiti minimi cord may extend fi-om the musculotendinous junction or 
tendon to the ulnar side of the base of the middle phalnyx. Commonly this cord 
will adhere to the lateral skin. The central cord is a direct extension of the 
pretendinous cord. The spiral cord develops from the pretendinous aponeurosis, 
spiral bands, the lateral digital sheaths, the vertical band and Grayson's ligament 
and usually connects to the middle phalnyx. The lateral cord results fi-om 
contracture of the lateral digital sheath.The retrovascular cord is described as a 
condensation of longitudinally orientated fibres deep or dorsal to the 
neurovascular bundle
The Australian surgeon Hueston (1963) believed that the nodules and bands 
excised were quite different firom the palmar aponeurosis. He felt they arose de 
novo. Now it is accepted that nodules, fascial bands and fibrofatty subcutaneous 
tissue are in physical and biological continuity making this theory less relevant.
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The normal stiiictures of the finger that may be involved in Dupuytren’s 
Disease are the longitudinal pretendinous bands, natatory ligaments, lateral digital 
sheaths and Grayson’s and Clelands ligaments, as illustrated in figure 2.
The three pathologic cords that may develop during the progressive palmar 
fibromatosis of Dupuytren’s disease are the central, the spiral and the lateral cords, 
as illustrated in figure 3.
(Reproduced with permission fi'om McFarlane RM; Patterns of the diseased 
fascia in the fingers of Dupuytren’s contracture. Plast Reconstr Surg 54:31, 1974 
and from Chiu HP, McFarlane RM: Pathogenesis of Dupuytren’s contracture: A 
correlative clinical-pathological study. J  Hand Surg 3:1-10, 1978)
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1.3 
HISTOLOGY
Much of the previous histological work has been disappointing in that it has 
contributed little to the understanding of Dupuytren's disease (Nezelof, 1974), It 
has confirmed fibrosis, as expected fi'om clinical observation and from operation, 
but lent nothing to suggest its aetiology or histogenesis. With modem tools 
available such as immunological and molecular biological analyses, more 
meaningful interpretation of the gross changes will be obtained.
The work of Hueston, 1963, suggested the nodules were histologically separate 
firom fascial tissue and that Dupuytren’s disease resulted firom an extrinsic 
pathogenic process to the pahnar fascia. However now it is generally accepted 
that the nodules, fascial bands and fibrofatty subcutaneous tissue are in 
physiological and biological continuity (Baird, 1994)
It appears that the disease evolves through several phases. In the palmar 
aponeurosis area the disease may be in different phases at any one time, 
separated by only millimetres.
Nodule Phase
Nodular areas of thickening are the actively developing and progressing areas, 
characterised by individual nodules of about equal size, round or oval and of 0,5 
to 1 mm in diameter. The nodules are highly cellular, consisting predominantly 
of fibroblasts arranged in an irregular but more or less concentric pattern. They
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are highly vascular and closely arranged together in the central part of the lesion, 
containing a network of fibres. On exiting the nodule, the fibres unfurl and 
elongate and increase in size to lie in a criss-cross fashion to form a dense 
complex mesh that with the myofibroblasts nodules constitutes the main 
component of the lesion.
Intermediate Phase
The intermediate lesions are characterised by morphological differentiation of 
these fibroblasts, which proliferate and migrate away from the vicinity of blood 
vessels. The fibroblasts develop elongated nuclei and acquire increased amounts 
of cytoplasm assuming morphological appearance of myofibroblasts. A more 
detailed discussion on the nature of these myofibroblasts is deferred to the 
section on chronic inflammation. Gradually the tissue becomes less cellular and 
the collagen content increases as does the ratio of type III to I collagen, and may 
spread to involve the dermis and epidermis. Foci of haemosiderin are sometimes 
noted resulting from micro-haemorrhages. A variable inflammatoiy cell infiltrate 
is seen, consisting of lymphocytes, monocytes, macrophages and masts cells.
Cord Phase
The cords are surmised to be areas where involution and maturation have 
occurred. The cords have heterogeneous texture with regular fasciculation. 
Cellular density is low, the few recognisable cells being fibrocytes lying 
longitudinally between collagen fibres. The collagen fibres are wide, elongated, 
and biréfringent when seen through polarised light and slightly arched. The more 
peripheral fibres seem looser and less ordered and are Periodic Acid-Schiff
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(PAS) test negative. The central fibres are thinner and more tortuous and are PAS 
positive and contain no elastin fibres. Strands occasionally run into the fat and 
adjacent tissue.
A summary classification of this was presented by Luck (1959) who divided 
Dupuytren's tissue into three stages; (1) proliferative (2) involutional (3) residual. 
In this the nodule represented the earliest stage of the disease in the process of 
proliferation. The involutional stage consisted of the fibroblasts orientating 
themselves along the major stress axes in the palmar fascia. Finally the residual 
stage ensued with the disappearance of the fibrous nodule, leaving only focal 
dense adhesions and relative acellular fibrous cords, almost similar to tendons. 
(Figure 4 a, b)
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Figure 4 a
Figure 4 b
Figure 4 a
A proliferative nodule: note the thickened vessel walls, some occluded, and the 
proliferating cells surrounding these vessels (Baird, 1994, reproduced with permission). 
Figure 4 b
Residual phase o f  Dupuytren’s contracture: note the hypocellular tissue with parallel 
bundles o f  collagen fibres resembling tendons (Baird, 1994, reproduced with permission).
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1.4
AETIOLOGY
Associated conditions
1 Alcoholism and Hepatic Cirrhosis
2 Epilepsy
3 Pulmonary fibrosis
4 Tuberculosis
5 Smoking
6 Diabetes Mellitis
7 Hypercholestaemia
8 HIV infection
9 Trauma
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1 Alcohol and Cirrhosis
Dupuyti'en (1834) implied the link between Dupuytren’s contracture and high 
alcohol intake. Certainly the incidence of alcoholism in populations of 
Dupuytren's contracture patients and the frequency of Dupuytren's contracture in 
populations of alcoholics has been studied. No universal agreement has yet been 
reached but correlation between alcoholic patients and higher rates of 
Dupuytren's contracture seems reproducible (Noble et al, 1992; Attali et al; 
1987; Houghton et al^ 1983). It should be noted that correlation between alcohol 
induced hepatic cirrhosis and Dupuytren's contracture is positive (Rafter et al, 
1980; Noble et al, 1992). This suggests alcoholics probably do have a higher 
rate of Dupuytren's contracture and that this effect may be largely due to the liver 
disease caused by alcohol abuse in genetically predisposed individuals.
2 Epilepsv
There is a statistical correlation between Dupuytren's contracture and epilepsy 
(Lund, 1941; Skoog, 1948) and idiopathic epilepsy seems to have a stronger 
correlation than post-traumatic epilepsy. The correlation does not appear to be 
due to anti-epileptic drugs (Noble et al, 1991), although there is some in vitro 
evidence that phenobarbitone causes dose related changes in factors that 
influence fibroblast growth and differentiation (Baird, 1994).
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3 Pulmonary Fibrosis and Chronic Obstructive Airways Disease
An association between pulmonaiy fibrosis and chronic obstructive airways 
disease and Dupuytren’s disease has been observed (Parrella et a l,  1987; 
Despierres et al, 1966).
4 Tuberculosis
Dupuytren’s contractuie has been reported to commence in many patients within 
one month of immobilisation in bed for pulmonary tuberculosis (Hueston, 1991), 
and this association was noted as early as 1966 (Despierres et al, 1966)
5 Smoking
There is an increased incidence of Dupuytren’s contracture in cigarette smokers 
(An et al, 1988).
6 Diabetes Mellitis
Diabetes mellitus has been noted to be associated with Dupuytren's contracture 
for over a 100 years (Viger, 1883), The incidence of Dupuytren's contracture in 
patients with diabetes mellitus has been estimated to approach 40% (Noble et al, 
1984). There appears to be no significant difference in Dupuytren's contracture 
incidence between non-insulin dependent and insulin dependent diabetics. 
Duration of diabetes appears to affect the incidence, as the incidence naturally
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increases with age; however it also increases with age in idiopathic cases. 
Suggestions have included an inherited predisposition to both diabetes mellitus 
and Dupuytren's contracture or that microangiopathy secondary to the diabetes 
mellitus may provoke fibroblast differentiation and proliferation.
7 HishLDL
Diabetes mellitus and hypercholestaemia, alcohol disease and smoking all lead to 
elevated lipid levels. Serum lipid levels were studied prospectively in relation to 
Dupuytren's disease. Dupuytren's patients had significantly higher fasting serum 
cholesterol and triglyceride levels than controls (Sanderson et al, 1992).
8 HIV Infection
A study of 50 male patients admitted with complications of their HIV infection 
found an incidence of Dupuytren's contracture of 36% compared to 0% for an 
age matched control gioup (Bower et al, 1990). The authors related this 
increased incidence to the elevated free radical activity noted in HIV infection, 
but the modulation of the pro-inflammatory cytokine profiles may also be 
involved, as will be discussed later.
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9 Trauma
Dupuytren's contracture has for years raised a controversy between whether acute 
traumatic injury or cumulative biomechanical work exposure could contribute to 
the development of this disorder.
Arguments against Dupuytren's being directly related to trauma include the 
observation that the condition is not any more common in manual workers than 
clerical workers. It appears bilaterally in some 40% of patients and the dominant 
hand is not more frequently affected than the non-dominant hand. It also has a 
familial incidence reportedly the same in identical twins and it is associated with 
fibrous growth elsewhere not associated with trauma e.g. Peyronie’s disease. In 
addition, injuries to the palmar fascia are certainly not always followed by 
Dupuytren's contracture. There are no reported accounts of increased incidence 
in sports people who wield clubs or rackets in a repetitive and traumatic manner 
(Fisk, 1985). Some histological studies have demonstrated circumstantial 
evidence of repetitive microtrauma, such as partial fascial ruptures, scarring in 
the subcutaneous tissue and haemosiderin deposits. However these could equally 
result as a consequence of Dupuytren's contracture rather than represent its cause.
An argument in favour of trauma being associated is Dupuytren’s increasing 
incidence with age, as this perhaps indicates that chronic minor trauma to the 
hand has a cumulative effect. Of more relevance is its association with some 
injuries to the hand and arm and its complications, for example, after Sudeck's 
dystrophy (Plewes, 1956) and frozen shoulder (Early, 1962). Indeed, Dupuytren's
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contracture has been reported to occur within weeks or months of a specific 
incidence such as a Colies fracture (Kelly et al, 1992) or metacarpal fracture 
(McFarlane and Shum, 1990a). One mechanism proposed is the tethering effect 
of the scar tissue within the palmar tissue. An alternative theory is the 
recruitment of a pool of inflammatory cells within the injured limb of a 
genetically susceptible individual, which then promotes a localised flbrotic 
response. This will be elaborated on later.
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1.5
GENETICS
Dupuytren's contracture affects both men and females but in 10:1 ratio in 
incidence. Ling (1963) studied 50 patients from the Edinburgh hand clinic and 
obtained knowledge of the whereabouts of lst/2nd/3rd-degree relatives, 
amounting to 832 relatives for further surveying. Dupuytren's contracture lent 
itself to such a survey, as examination of the hands and feet of people at home 
without X-rays is satisfactory and therefore large numbers may be screened. 
However such surveys are problematic, in that many individual relatives will be 
too young to manifest Dupuytren's contracture, although they may well develop 
it. Despite these drawbacks, when weight adjusted for age, the results of the 
survey correlated very well with those that would be expected for an autosomal 
dominant inheritance (Figure 5). This has since been supported by other work 
(James, 1985). Other patterns of inheritance are unlikely as the ratio of affected 
males to females is unchanged in first degree relatives making sex-linked 
transmission unlikely and as the rates amongst parents, siblings and children are 
comparable it lessens the likelihood of polygenic inheritance.
Several cytogenetic studies have been completed. Chromosomal abnormalities 
are commonly detected in cell cultures from Dupuytren's tissue but the only 
consistent finding so far have been for trisomy of chromosome 8 (Bonnici et al, 
1992). Interestingly, chromosomal aberrations including trisomy 8 have also 
been noticed in palmar fascia from carpal tunnel decompressions, suggesting a 
potential for chromosomal instability in this fibrous structure. Trisomy 8 has also
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been detected in some large bowel tumours and mixed salivary gland neoplasms, 
the latter resembling Dupuytren's contracture in their high frequency of local 
recurrence following excision. Trisomy 8 has also been noted in the penile 
fibrosis of Peyronie’s disease. However as yet there is no definitive evidence to 
suggest chromosomal abnormalities alone cause transformation of the palmar 
fascia in Dupuytren’s contracture.
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Figure 5
Two illustrative family trees from Ling’s series are portrayed here. They 
illustrate the autosomal dominant pattern of inheritance. The second family tree it is 
probable that the trait was brought together by both the father and the mother in 
generation II and the siblings are homozygous for this abnoimality; severe 
Dupuytren’s occurred early in several of the family. It would seem possible that 
expression in homozygotes for this disease is earlier than average. Such individuals 
cannot be rare in so common a dominant inherited disease.
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1.6
EPIDEMIOLOGY
Dupuytren's disease has a suggested prevalence of 1-3% (Viljanto, 1973), but the 
prevalence varies widely in different parts of the world (Strickland et al, 1990).
It is virtually confined to Caucasians with only very occasional reports in black 
individuals with a prevalence of only 0.0007% in South Africa, (Mennen, 1986). 
The true incidence of Dupuytren's contracture is also difficult to establish. In the 
United Kingdom, an incidence was determined in those over 75 years of 18.1% 
for men and 9% for females (Early 1962).
Certainly there is a comparatively steady increase of Dupuytren’s contracture 
with advancing age (Skoog, 1948). Why women are significantly less often 
affected by palmar fibrosis than men is unknown. Male to female ratios is 
reported as approximately 9 to 1 or 7 to 1, changing with progressive age to 3.7 
to 1 (Skoog, 1948; Berge and Pohl, 1988). The reason for such varied sex ratios 
may be partly explained due to earlier affliction of males with Dupuytren’s 
disease. If they are operated on more often at an early stage, then surgical 
statistics will overestimate the true male: female ratio. Estimates of the sex ratio 
should only be accepted with some reserve.
Dupuytren’s contracture is not coincidental to the dominant versus non-dominant 
handiness (Hueston, 1987). Two thirds of patients show bilateral affliction 
(McFarlane, 1990b). More operations are undertaken on the right hand as the
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majority of patients are right handed and contracture of the dominant hand will 
have a greater effect on function, leading them to present to the surgeon.
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1.7
SURGICAL INTERVENTION
The mere presence of Dupuytren's nodules and cords is not an indication to 
operate. The aim of surgery is to restore function. Increasing palmar changes 
lead to flexion contracture which results in the functional impairment that the 
patient complains of is an indication for surgery, and intervention is definitely 
indicated where increasing induration and cord formation produces distinct 
extension deficit.
No one method to treat Dupuytren's contracture is perfect and all have 
disadvantages and associated morbidity.
Astley Cooper, ten years prior to Dupuytren’s naming the disease, performed a 
percutaneous fasciotomy, which is simple division of the cord. Later Luck (1959) 
advocated removing the nodule in addition to a fasciotomy. Indications for 
fasciotomy were reported by Colville (1983), the chief criterion being a well 
defined pretendinous cord with bow stringing across the palm, said to indicate 
the absence of deep fascial connections. If the skin and cord were extensively 
attached, preventing the cord sliding distally after the division, then a fasciotomy 
was contraindicated. Although there was short-term improvement in metacarpal- 
phalangeal joint contracture, the long-term results were not as good for 
metacarpal-phalangeal joint contracture as those expected from a limited 
fasciectomy (McFarlane and Botz, 1990c), which is correction by removal of the 
fascia. However, fasciotomy may be acceptable in elderly and infirm patients
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where the risk of recurrence may be accepted because of the simple 
uncomplicated nature of fasciotomy.
McCash (1964) described an open palm technique with a transverse palmar 
wound left open. In a primary case there is no loss of skin, healing occurring by 
contracture of the transverse palmar wound drawing the skin out to its original 
length and not by growth of new epithelium over the wound (Lubahn et al,
1984). This technique gives good access for removal of diseased palmar fascia 
but it is controversial in its use in recurrent disease, as although allowing good 
drainage, it will not overcome a true shortage of skin. In addition, it does require 
convalescence period of 4 to 6 weeks as opposed to 2 weeks if a closed technique 
is used.
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Some complications and unsatisfactory results
The only sure way to prevent a surgical complication is to not operate. Bearing 
this in mind, complications, which are due to the surgeon’s intervention, include 
the following: incisional skin contracture, skin necrosis neurovascular damage 
and joint stiffness.
Incisional scar contracture is dependent on the siting of the incision. Longitudinal 
incisions over the finger allow easy identification and protection of the 
neurovascular bundles but necessitates interruption by Z plasties or full thickness 
skin grafts at closure to prevent contraction. Zigzag and V-Y exposures combine 
longitudinal access with a low risk of scar contracture, but with flap tip necrosis 
as a risk. Long transverse incisions of the palm leave no problem of scar 
contracture but need meticulous haemostasis for closure or the resulting 
haematoma may cause flap necrosis.
Skin necrosis is a consequence of raising flaps over extensive and invasive 
Dupuytren's tissue. A balance has to be maintained between excision of all 
diseased tissue and preservation of the dermis of the flap. If the patient’s 
diathesis is very strong then dermofasciotomy and replacement with full 
thickness skin graft may be the preferred management. Z plasties in longitudinal 
excisions should be placed at the end of the operation once flap viability is 
ascertained.
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Neurovascular damage should be avoided and the bundle is rarely affected in 
primary disease. In recurrent disease, the digital nerve and artery are often 
involved and it is better to leave a little tissue surrounding the bundle than 
damage it. Such damage can result in persistent cold sensitivity and even distal 
gangrene.
It is important to avoid joint stifftiess, as it determines the functional level of the 
hand. Early postoperative proximal inter-phalangeal joint stiffness is associated 
with a swollen hand or local painful focus such as stitch or scar adhesion or 
nerve irritation and can usually be easily corrected. Some patients, more often 
women, may develop fusiform swelling and pain of the proximal phalangeal 
joints 2 or 3 weeks after uncomplicated surgery. Despite protracted 
physiotherapy many have residual loss of grip strength and function.
Any open operation may result in infection and for the avoidance of necrosis, 
haematoma formation and good surgical technique is required.
RECURRENCE
Recurrence is defined as the development of new Dupuytien's tissue appearing in 
the previously operated area, and should be distinguished from extension of the 
disease to an unoperated area. Rates of recurrence have greatly varied in different 
series fi'om 20 to 68% (Leclercq and Tubiana, 1993). However, there now seems 
to be a general consensus that the longer the follow up the higher the rate of 
recurrence (Leclercq and Tubiana, 1993). Many factors appear to influence the
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chance of recurrence. The two most important are age of presentation, a young 
age of first operation being associated with a high risk of recurrence, and the 
existence of previous recurrence. Other factors that increase the chance of 
recurrence include: a family history, ectopic lesions, epilepsy, incomplete 
correction of the contracture, female sex and surgical complications (Table 1).
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Table 1
Influence of various factors on recurrences (Leclercq and Tubiana, 1993)
Factors Patients (no.) Recurrence (no.) Percent
Age
<45 16 16 100
45-65 18 12 66
>65 9 4 44
Familv Historv
Positive 14 11 78
Negative 24 14 58
Previous
Recurrence 6 6 100
An almost total absence of recurrence has been noted under full thickness skin 
grafts and these have therefore been advocated for young or strong diathesis 
patients or in recurrent cases (Leclercq and Tubiana, 1993). The underlying 
mechanism for this is not entirely clear.
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1.8
ALTERNATIVE MANAGEMENTS
Since the time of Dupuytren himself, attempts have been made to either alleviate 
the symptoms or stop progression of Dupuytren's contracture with drugs and 
alternative remedies, ranging from calomel lotion to simple sulphur and leeches, 
all without significant beneficial effect. Such treatments represent a desire to 
avoid the risk of operating. Gilbert (1913) and Wainwright (1926) gave thyroid 
extract and Noix (1946) used fibrinolysin thiocimin electroiontophoretically, but 
not effectively, to soften the collagen contracture.
In contrast to mere softening, collagen degradation was tried with pepsin (Hesse 
1931) and later with trypsin, a  chymotiypsin and hyaluronidase (Bassot 1969; 
Hueston 1971). Despite pronounced effects of this chemical fasciotomy the 
treatment was unpredictable and had associated morbidity including 
neurovascular damage and occasional skin necrosis and was not widely accepted.
Vitamin E has also been used in Dupuytren's contracture, having been 
successfully used in the treatment of Peyronie’s disease (Burford and Burford, 
1957). Treatment of Dupuytren's however, produced variable results from good 
(Steinberg, 1946; Steinberg, 1951) to ineffective (King 1949; Richards 1952).
Recently, radiotherapy has been tried to prevent disease progression from early 
nodule formation (Keilholz et al, 1996). Long-term follow-up of treated patients
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suggested dramatically reduced progression rates and reduced symptoms, with no 
recorded acute or late treatment radiation toxicity.
Steroids have heen used successfully on other fibromatosis such as Peyronie’s 
disease, hypertrophic and keloid scarring (Rothfield and Murray, 1967; Bodner et 
al, 1954; Ketchum et al, 1974). Steroids certainly appeared to halt progression 
of Dupuytren’s disease, but did not affect established contractures. In addition, it 
facilitated movement and reduced oedema post-operatively and increased the rate 
of rehabilitation generally (Bernstein, 1954). This certainly suggested that ways 
to prevent disease progression from early nodule formation exist and could 
prevent otherwise necessary surgical procedures being performed in advanced 
stages of Dupuytren's contracture.
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1.9
CURRENT THEORIES
Current theories individually fail to explain all the features observed in 
Dupuytren's contracture.
Hueston, as mentioned previously, proposed an intrinsic and extrinsic theory of 
pathogenesis (Hueston, 1963). The intrinsic component was thought to lie within 
the aponeurosis itself, resulting from presumed microruptures in the fascial bands 
and the resulting altered physical compliance of the palmar fascia as mechanical 
initiating factors. The extrinsic contribution comprised the development of 
primaiy nodules in the subcutaneous fat, superficial to the aponeurosis. It now 
appears these two structures are in physical and biological continuity, so this 
theory adds little to our understanding of Dupuytren's contracture.
Another theory is that Dupuytren's contracture is a sequence of responses of the 
palmar fascia to injurious stimuli, rather than a disease in its own right (Flint and 
McGrouther, 1990). Factors such as diabetes and alcoholism by altering the 
properties of the palmar fascia facilitated pathological change. The Dupuytren's 
contracture nodule was viewed as a localised repair reaction in the fascia. The 
early 'trigger' event is proposed as a loss of bulk in the subcutaneous fat pad 
resulting in increased stress on the intra-fascial 'core' collagen fibres. This is an 
elaborate adaptation of the 'cumulative tr auma theory', which failed to adequately 
explain similar rates of occurrence in manual labourers and office workers or 
similar rates for bilateral contracture, or the racial and geographical differences.
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Some degree of fascial rupture will occur for most people every day, yet only a 
minority develops Dupuytren's contracture.
Tissue hypoxia has also been proposed, but it is not clear if the micro-circulatory 
changes are a primary or secondary effect of Dupuytren's disease. Tissue oxygen 
perfusion changes were investigated (Kischer and Speer, 1984) and Murrell et 
al^ went even further, suggesting localised ischaemia results in elevated levels of 
the purine bases xanthine and hypoxanthine (Murrell et al, 1987). This promotes 
conversion of xanthine hydrogenase to xanthine oxidase, which catalyses the 
oxidation of these bases and releases superoxide radicals and hydrogen 
peroxide, both of which can be toxic to cells. It was theorised that 0^‘ free 
radicals may trigger fibroblast proliferation and centrifugal chemotaxis from the 
angiocentric nodules. A positive feedback could be created where free radicals 
cause further damage to the pericytes, thickening of capillaiy basal laminae and 
sustained fibroblast proliferation. Against this theory is the fact there is no 
increased incidence of Dupuytren's contracture in gout where levels of xanthine 
and hypoxanthine are certainly elevated (Adam and Loynes, 1992). The true role 
of free radicals needs further evaluation.
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1.10
CHRONIC INFLAMMATION
Tissue responds to insult with an attempt to repair itself. This response can be 
divided into an inflammatory response, a fibroproliferative response and a 
remodelling response. In the pathological state, acute inflammation becomes 
chronic with resulting excessive fibroproliferation and subsequent fibrosis. 
Fibrosis is characterised by a qualitative and a quantitative alteration of 
extracellular matrix deposition, and with excessive accumulation of 
mesenchymal cells.
A similar sequence of events occurs in wound healing with the transient 
formation of limited normal granulation tissue, whereas in fibrosis a maladaptive 
repair leads to an extensive, exaggerated process with consequent functional 
impairment. Inflammatory cells (predominantly macrophages, but also T 
lymphocytes, neutrophils, eosinophils), platelets, and fibroblasts / myofibroblasts 
play a direct and indirect role in this tissue injury and repair.
1.10.1
Inflammatory Response with Transendothelial migration
The composition and distribution of the inflammatoiy infiltrate at sites of 
inflammation seem to be mediated by a variety of factors relating to the causative 
agent, its nature, location, duration and the histo-specific regulation of the local 
inflammatory responses. The local production of pro-inflammatory agents, the 
selective expression of cell type-specific adhesion molecules and the generation
52
of specific gradients of chemotactic and haptotactic molecules have been 
recognised playing a key role in leukocyte recruitment, efficient routing and 
persistence at sites of inflammation
1.10.2
Inflammatory cells in Dupuytren's disease
The presence of inflammatory cells has been noted in Dupuytren's tissue by 
many authors (Andrews et al, 1991). Work in this department demonstrated the 
heterogeneous nature of the cells present in Dupuytren's contracture (Baird et al, 
1993a). Using flow cytometiy, the peri-nodular tissue was demonstrated to 
contain a suiprisingly high proportion of T lymphocytes and macrophages 
(Baird, 1993a). This was later confirmed in tissue sections using histology and 
immuno-histochemistry, where having looked at seventeen samples of 
Dupuytren's tissue, all stained positively for CD3, CD68 and MAC387 antibody 
markers (Figure 6). This compared with only 1 positive histology section (for 
CD3 only) out of 5 control samples of palmar fascia. T lymphocytes were the 
most prominent inflammatoiy cells present, usually occurring in large clusters 
next to blood vessels and between the fibres in the nodule itself. Macrophages 
and mast cells were in much higher numbers in the Dupuytren’s tissue than in 
palmar fascia control sections, and lay between the fibroblasts and around the 
blood vessels in the connective tissue, which penetrated into the nodule.
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Figure 6
Sections of Dupuytren’s tissue stained by immuno-histochemistry: demonstrating 
CD3 antigen for human T cells positive cells in (a) on fluorescein staining (x 320 
magnification); Staining for CD68 antigen, another T cell marker, in (b) 
demonstrating positive cells in the peri-nodular Dupuytren’s tissue (x 128 
magnification); (c) MAC387 antigen for human macrophages stained several cells 
around many blood vessels with peroxidase immuno-histochemical staining (x 128 
magnification); (d) Again CD3 antigen positive cells demonstrated lying along 
blood vessels (x 320 magnification), this time stained by peroxidase immuno- 
histochemistry. These sections represent unpublished work from Baird et al.
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1.10.3
Fibroproliferative Response
Several pro-inflammatory cytokines participate in the local injury and 
inflammatory reaction (IL-1, TNF-alpha, PDGF, TGF-beta, bFGF and IL-8) and 
these have been demonstrated to be present in Dupuytren’s tissue (Baird, 1994).
Inflammatoiy Cell Signalling Molecules In Dupuytren's Disease
Abnormal local regulation of cytokines and growth factors, which 
stimulate Dupuytren’s fibroblasts and matrix synthesis, has been demonstrated 
by several authors now. Specifically PDGF (Badalamente, 1992, Aliota, 1994, 
Terek, 1995, Baird, 1993b), IL-1-alpha and beta (Baird, 1993b), TGF-beta 
(Baird, 1993b) and bFGF (Baird, 1993b). The todate unpublished results of this 
departments immunohistochemistry studies of IL-1-alpha and beta, IL-4, IL-6 
and TNF-aipha is expressed in Table 2.
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Table 2
Immunohistochemistry results for Dupuytren's tissue
Patients IL-l-alpha IL-1- beta IL-4 IL-6 TNF-aloha bFGF
Sample
1 4- 4- 4“ 4- 4- 4-
2 + + 4- 4“ 4- 4-
3 4- 4“ 4- 4- 4- 4-
4 4" 4- 4- 4- 4- +
5 - - wk - wk wk
6 4- + + wk 4- 4-
7 + 4- + 4- 4- wk
8 4- 4- 4- + 4- 4-
9 4- 4- + 4" wk 4-
10 4- 4- 4- 4- + 4-
IL-1-alpha stained positively on immunohistochemistiy in the endothelial cells of 
many blood vessels entering the nodule and was particularly strong in small 
capillaries. It also appeared in the Dupuytren's fibroblasts in mature, large 
nodules and very positive in macrophages around the blood vessels and nodules. 
IL-1-beta had a similai* staining pattern to IL-1-alpha (Figure 7a).
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TNF-alpha was detected again in the endothelial cells of many blood vessels, 
including some but not all of the small capillaries. Tissue macrophages and 
migrating monocytes stained positively but the fibroblasts did not express TNF- 
alpha. Sweat glands stained strongly positive (Figure 7a).
IL-4 stained positively in inflammatory cells generally and in particular in 
lymphocytes present in clusters (Figures 7a & 7b). IL-6 was present in the 
endothelial cells of small capillaries, but in general the cells of the main blood 
vessels were negative.
bFGF was strongly staining in the sweat glands, but also present in the 
endothelium of capillaries and larger blood vessels. Some Dupuytren's 
fibroblasts, mainly in the centre of the nodules, also expressed bFGF. (Figure 7a)
Sections from five pahnar fascia control patients demonstrated either no positive 
staining or only very weak and non-specifically localised results
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Figure 7a
Sections of Dupuytren’s tissue stained for IL-1 alpha / beta, TNF-alpha, IL-4, bFGF
and IL-8 by and visualised with Fast Red TR/Napthol AS-MX Phosphate (Intense
red stain positive).
(1) IL-1-alpha production is demonstrated in fibroblasts and endothelial cells of 
blood vessels of the fibrofatty area of Dupuytren’s tissue (x25 magnification).
(2) TNF-alpha distribution at the edge of a nodule is mainly in the blood vessels 
and migrating monocytes (xlO magnification).
(3) IL-4 stained endothelium and inflammatory cells at one of the areas where 
blood vessels penetrate the nodule (x25 magnification).
(4) bFGF stained strongly in the endothelium of capillaries and larger blood 
vessels at a fibrofatty area of Dupuytren’s tissue (x25 magnification).
(5) IL-1 -beta is expressed in a similar distribution to IL-1-alpha production in 
fibroblasts and endothelial cells at the edge of a nodule (x25 magnification).
(6) IL-8 production in the fibrofatty area was seen in both the endothelial cells of 
blood vessels and by some Dupuytren’s fibroblasts (x25 magnification).
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Figure 7b
Section of Dupuytren’s tissue stained by immuno-histochemistry for IL-4 antibody 
and visualised with Fast Red TR/Napthol AS-MX Phosphate (Intense red stain 
positive). Expression of IL-4 by a T cell contained in a blood vessel and starting to 
penetiate into the nodule (Magnification x320).
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Transforming Growth Factor Beta
TGF-beta is a group of cytokines, of which isoform types 1 and 2 are known to 
stimulate the synthesis of extracellular matrix and integrin expression in vitro, 
and has been identified in chronic inflammatory sites (Roberts et ai, 1986; 
Ignovitz and Massague, 1986; Wahl et al, 1993; Massague et a/., 1991; Raghow 
et al, 1987). TGF-beta by augmenting integrin expression may promote 
leukocyte adhesion to vessel walls and stimulate mononuclear cells to release 
further cytokines, refuelling the cycle. Functionally TGF-beta promotes 
monocyte adhesion to type IV collagen, laminin and fibronectin. This represents 
one mechanism as to how TGF-beta may facilitate monocyte margination and 
accumulation at a TGF-beta producing site (Wahl eta l,  1993). TGF-beta also 
increases gelatinase type IV collagenase and this could potentiate monocyte 
migration through the extracellular matrix (Wahl et al, 1993).
TGF-beta also can act as an immunosuppressant modulator. Kulkami 
demonstrated that TGF-beta knockout mice have remarkable infiltrations of 
mononuclear leukocytes into multiple organs (Kulkarni and Kaiisson, 1993).
This suggests TGF-beta can on occassion promote fibrosis while diminishing 
inflammation. It may be the balance between the three known TGF-beta isoforms 
and their receptors that underlies this balance. These paradoxical fimctions of the 
TGF-beta molecule do not detract from its pivotal role in inflammation and 
fibrosis. Understanding these complex relationships and their subsequent 
modulation will be necessary to control fibrosis.
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Interleukin-8
IL-8 is part of the chemokine family. Chemokines are divided into two 
subfamilies depending on the arrangement of the first two of four conserved 
cysteines, which are separated by one amino acid into the CXC chemokines and 
CC chemokines. IL-8 is a member of the CXC chemokines.
Increased expression of IL-8 has been reported in a number of inflammatory 
disorders characterised by leukocyte infiltration, including rheumatoid arthritis 
(Seitz et al., 1991), psoriasis (Sticherling et al, 1991), gout (Terkeltaub et al,
1991) and idiopathic pulmonary fibrosis (Car et al, 1994). Both the interleukin 
protein itself and the two identified IL-8 receptors appear to have critical roles. 
Anti-IL-8 antibodies reduce tissue damage from inflammation in animal models 
(Hardaefa/., 1994).
IL-8 can degranulate neutrophils releasing substances, which attract T 
lymphocytes and monocytes (Taub et al, 1996). IL-8 is produced by several cell 
types, including endothelial cells (Sica et al, 1990), epithelial cells (Elner eta l,  
1990, Standiford, e ta l,  1990), fibroblasts (Larsen eta l,  1989), neutrophils 
(Schroeder et al, 1988), peripheral blood monocytes (Yoshimura et al, 1987), 
tissue macrophages (Koch et a l, 1991), T lymphocytes (Schroeder et al, 1988), 
kératinocytes (Larsen et al, 1989), and chondrocytes (Recklies and Golds,
1992).
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Prostaglandin E2 (PGE2) enhances IL-8 production by synovial fibroblasts after 
stimulation with IL-1 (Agro et al, 1996) and PGE2 production is elevated in 
Dupuytren’s tissue (Badalamente et al, 1988).
Human macrophages loaded with cholesterol produce more IL-8 mRNA and IL- 
8 itself into the medium (Wang et al, 1996). High levels of LDL are seen in 
hypercholestraemia, diabetes mellitis and smoking all associated with increased 
incidence of Dupuytren's disease (Cathcart et al, 1985).
In addition to IL-1 alpha and beta and TNF-alpha, Dupuytren's fibroblasts have 
now been shown by culture experiments and confocal microscope results to 
produce significantly more IL-8 than skin fibroblasts on IL-1 stimulation (Meek 
et al, 1996), (Figure 8). This might suggest that Dupuytren's patients have a 
genetic defect resulting in the presence of a clone of palmar fibroblasts that when 
stimulated with increased levels of IL-1 or TNF-alpha produces sustained levels 
of IL-8 (Meek et al, 1996). Such prolonged production of IL-8 would lead to 
chronic inflammatory cell infiltration by virtue of its leukocyte chemoattraction 
and promotion of angiogenesis. The fibrogenic cytokines subsequently produced 
by both the inflammatory cells and fibroblasts would lead to fibroblast 
proliferation, matrix synthesis and ultimately fibrosis.
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Figure 8
IL-8 fluorescent-labelled antibody binding analysed by a confocal microscope for 
normal skin cultures and Dupuytren’s cell cultures. The top two squares show 
control cell cultures of normal skin cells obtained from penile foreskin, (a) is un­
stimulated and (b) has been stimulated with lipopolysaccharide. There is a little 
increase in IL-8 expression. This compares with the Dupuytren’s cultures below. 
Even in the un-stimulated Dupuytren’s cultures (c) there is a higher baseline 
production o f Interlukin-8 than the stimulated normal skin cells. Once stimulated 
(d) there is a dramatic increase in Interleukin-8 production. The confocal 
microscope allowed quantification o f this production by calibrated light units.
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Parallel to Dupuytren’s disease, idiopathic pulmonary fibrosis can be divided 
into a subacutely progressive phase and a chronically progressive phase. This is 
similar to the nodule (proliferating) and cord (endstage) of Dupuytren's disease. 
IL-8 protein levels from bronchoalveolar lavage fluid were increased in 
subacutely progressive state but not in patients with the chronic stage. However 
if macrophages were isolated from the lavage of chronic phase patients and then 
stimulated with lipopolysaccaride they produced significantly more IL-8 than 
macrophages from control subjects. These patients had macrophages primed for 
IL-8 production even if they were not producing it in the chronic state.
(Nakamura et al, 1995). This is also true for peripheral blood monocytes and 
endothelial cells in chronic pulmonary disease (Streiter et al,  1990).
This may explain why there is an increased incidence of Dupuytren's disease in 
people suffering from chronic pulmonary airway disease, idiopathic pulmonary 
fibrosis and hypercholestaemia, as these conditions are associated with cells with 
increased sensitivity in producing IL-8. This genetic predisposition may also 
predispose the Dupuytren's fibroblasts for IL-8 production as well.
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1.10.4
Extracellular matrix
The extracellular matrix is composed of various cell-adhesive glycoproteins, 
such as fibronectin, laminin and different types of glycosaminoglycans and 
proteoglycans. Collagen is the major protein of the extracellular matrix 
(Burgeson, 1988). These building blocks are linked together to form a dense and 
complex tissue that fills the interstitial spaces. This is the medium that immune 
cells find themselves situated in during inflammation. Recognition of 
extracellular matrix molecules by the immune cells is mediated by very late 
activation (VLA) receptors (Hynes, 1992). Like cytokines, the cell-adhesive 
glycoproteins of the extracellular matrix affect cell activation, adhesion, 
proliferation and differentiation (Cahalon et al, 1994).
Of all the matrix proteins, fibronectin is of particular relevance as it anchors the 
myofibroblast of inflammatory tissue to the extracellular matrix and thus is 
integral to the contraction process. In addition fibronectin is now known to bind 
to many of the inflammatory cells found in chronic inflammatory conditions and 
is present on the endothelium as well as in the extracellular matrix. Fibronectin 
shows a widespread pattern of expression in development as well as 
inflammation and repair. Cell surface receptors exist in fibronectin for many 
integrins and cell-surface proteoglycans and the integrin receptors have been 
mapped to specific sites in the fibronectin molecule. Work on the three 
dimensional structure of fibronectin defined repetitive sequences that were 
responsible for integrin recognition (Fffench-Constant, 1995). For example, CSl
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and e s  5 sequences of the IIICS region of fibronectin is the receptor for aAp\ and 
the RGD sequence lying within the type III repeat is recognised by aSp\, (Figure
9).
The extracellular matrix in Dupuytren's
In the normal palmar fascia, the fibroblasts are embedded in an extracellular 
matrix containing parallel bundles of collagen fibrils. In the Dupuytren’s 
diseased fascia, the nodules are characterised by abundant myofibroblasts and 
these are surrounded by a tight network of thicker and longer branched collagen 
filaments. At distances greater from the cells, the collagen fibrils become 
irregularly orientated. In the cords, there are only a few myofibroblasts, which 
are closely packed between large bundles of collagen fibrils. In the nodules, the 
matrix around the myofibroblasts usually contains predominantly proteoglycans. 
The proteoglycans connect the cells with the collagen fibrils and to each other 
(Badalamente et al, 1983; BrickleyParson et al, 1981; Chiu and MacFarlane, 
1978).
Fibronectin is of particular interest, as studies have demonstrated that it is the 
anchoring protein for the myofibroblasts in Dupuytren's tissue (Tomasek et al, 
1986). Fibronectin has one particular site that binds to a subgroup of 
inflammatory cells cariying the aApi integrin and is called the CSl domain. The 
aAp\ integrin is common to the predominant inflammatory cells found in 
Dupuytren's tissue and is also the ligand for VCAM-1 adhesion molecules 
expressible on endothelial cells.
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Other work has looked at the extracellular matrix around the myofibroblast in 
Dupuytien's tissue specifically (Bemdt e ta l,  1994) demonstrating fibronectin 
within the whole palmar aponeurosis and in particular within the proliferative 
areas, whereas laminin, collagen type IV and tenascin labelling was restricted to 
the alpha-smooth muscle actin positive proliferative nodules.
The integrin aAp lis a cell surface heterodimer expressed on most mononucleai* 
leukocytes, eosinophils and basophils (Helmer eta l,  1990; Bochner e ta l,  1991). 
It has been shown to mediate cell adhesion to VCAM-1 (Elices et al, 1990; 
Carlos et al, 1991; Hakkert et al, 1991; Tiisla et al, 1993; Osborn et al, 1992a; 
1992b; Vonderheide and Springer, 1992) as well as the HepII/IIICS region of 
fibronectin at which the CSl site has the greatest aAp\ binding activity (Guan 
and Hynes, 1990; Wayner et al, 1989; Humphries et al, 1986; Humphries et al, 
1987; Humphries, 1990; Mould and Humphries, 1991).
Fibronectin expression has been studied in Dupuytren’s disease (Tomasek and 
Haahsama, 1991; Berndt et al, 1994; Halliday et al, 1994) and its co-expression 
with a4^5 integrin expression on stromal cells (Magro et al, 1995). This study 
demonsti'ated the distribution of the CSl site of fibronectin and VCAM-1 along 
with aAp 4 integrin expression to which they both bind and relate this with the 
production of the TGF-beta. It has already been demonstrated that in vitro 
cultured Dupuytren’s cells produce TGF-beta, and that TGF-beta stimulates 
Dupuytren’s fibroblasts to grow (Kloen et al, 1995).
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1.10.5
Myofibroblasts
Myofibroblasts occur in granulation tissue and healing wounds. Their properties 
are associated with tissue contraction and hypertrophic healing. A reduction in 
their numbers is associated with the start of the maturation phase of repair and 
abatement of contraction.
Myofibroblasts have several ultrastructural and biochemical features of smooth 
muscle with microfilament bundles and alpha smooth muscle actin. The micro- 
filaments are associated with pH dependent tiiphosphate necessary for cellular 
contraction in muscle. These anchoring strands of actin bundles bind to collagen 
fascicles in the extracellular matrix by strands of fibronectin (Bauer and Parks, 
1983). The cells contain vimentin and desmin. Four different types of 
heterogeneous phenotypes of myofibroblasts exist in different tissues based on 
the contained combination of vimentin, desmin and a  smooth muscle actin 
(Skalli eta l,  1989).
When chronically inflamed tissue resolves into a scar then alpha smooth muscle 
actin containing myofibroblasts disappear, possibly by apoptosis (Schmitt-Graff 
et al, 1994). If the tissues remain inflamed the myofibroblasts remain and 
together with increased extracellular matrix production result in contraction. 
Myofibroblasts accumulation in fibrosis may be at least in part due to local 
proliferation (Hewitson er 1995).
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Previously fibroblasts have been thought of as a homogenous non-differentiating 
cell population. When analysed by molecular biological methods, fibroblasts 
appear to exists as 11 cell types with biological and biochemical individuality 
developed along 11 different stages of differentiation sequences in 5 
compartments under the control of genetic programs (Bayreuther et al, 1995). 
This differentiation is maintained in fibroblast populations in pathological 
manifestations, from fibrosis to Duchenne muscular dystrophy or neoplastically 
transformed cell lineages. All these cell systems appear to be stem cell systems 
with a design resembling the design of the fibroblast stem cell system. Are 
certain cells preprogrammed to become myofibroblasts?
Alternatively, if myofibroblasts are transformed cells then what controls the 
alpha smooth actin expression in fibroblasts? Factors appear to include increased 
TGF-beta, heparin binding sites, or a reduction in a  interferon or cell density 
(Tomasek et al, 1999; Gressner and Bachem, 1994).
The activation of lipocytes and fibroblasts to a myofibroblast is triggered in the 
liver by the release of platelet-derived growth factor (PDGF) and TGF-beta from 
activated Kupffer cells (Schuppan et al, 1995). TGF-beta-1 also differentiated 
ocular trabecular meshwork cells to myofibroblasts phenotype (Tamm et al, 
1996). Bachem showed that TGF-beta-1 and TNF-alpha could stimulate the 
trans-differentiation of fat storing cells in the rat liver into myofibroblasts in 
association with increased fibronectin synthesis (Bachem et al, 1993). Cells with
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the myofibroblast phenotype are more abundant in fibrotic lung using a 
bleomycin-treated model and these cells possessed greater contractile capacity in 
vitro at least in part due to increased endogenous TGF-beta-1 gene expression 
(Zhang e/a/., 1996).
Myofibroblast differentiation can be induced in fibroblasts by plating them at 
low density and these myofibroblast enriched cultures in turn produce more 
latent and active TGF-beta than high density fibroblast enriched cultures (Masur 
et al, 1996). This suggests a cell density model of myofibroblast differentiation, 
where loss of cell contact could stimulate TGF-beta production.
Myofibroblasts In Dupuytren's Tissue
The myofibroblast characteristic of Dupuytren's tissue has been an area of much 
research. The origin of this cell in Dupuytren's tissue as with other 
myofibroblasts remains uncertain (Gown, 1990; Kisher and Speer, 1984), with 
some suggesting they arise from the 'pericyte' or perivascular cells. Others 
suggests it is simply a transient form of fibroblast (Andrews et o/., 1991) or it is 
derived from smooth muscle cells (Darby et al, 1990) or both (Schürch et al, 
1990). Ehrlich, (1990) believed the myofibroblasts orientated and fixed the 
collagen (Ehrlich and Rajaratnam, 1990). Whatever its origin, the expression of 
smooth muscle actin phenotype correlates with increased contractility in 
Dupuytren's myofibroblasts (Tomasek and Rayan, 1995). Dupuytren's fibroblasts 
are thought to have increased sensitivity to oxygen free radicals leading to 
myofibroblast differentiation (Murrell, 1992)
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Dupuytren's myofibroblast aggregates contract in response to PGF2 alpha and 
relax in response to PGE2. PDGF was associated with myofibroblast as shown 
by immuno-histochemical staining (Badalamente et al, 1992). Both bFGF and 
PDGF were mitogenic for Dupnytren's cell cultures, and TGF-beta potently 
stimulated collagen production by Dupuytren’s fibroblasts (Alioto et al, 1994). 
These 3 factors are elevated in Dupuytren's tissue and they and other macrophage 
mediated growth factors with their interrelated effects on Dupuytren's cells needs 
further delineation. The questions is, are there different myofibroblast 
phenotypes in Dupuytren's nodules, or are they the same phenotype at different 
temporal stages?
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1.10.6
Nitric Oxide
Nitric oxide (NO) is a firee radical gas, which is implicated as a secondary 
messenger molecule in many biological pathways (Clancy and Abramson, 1995). 
NO is generated by the conversion of the amino acid L-arginine to L-citrulline in 
a reaction catalysed by a family of isoenzymes, arising from three distinct genes. 
These types are (1) neuronal (nNOS), (2) inducible (iNOS) and (3) endothelial 
(eNOS). The inducible form iNOS is induced by many pro-inflammatoiy 
cytokines and is thought to be calcium dependent. iNOS is generally seen in 
pathological conditions where its induction results in the production of large 
quantities of NO. NO in low levels of production can act as a scavenger of 
superoxide anion (Midorikawa and Ogata, 1996) and in this role could serve as a 
defensive function by protecting tissues against super-oxide-induced 
inflammatory cell release of frbrogenic mediators. The NO molecule in high 
levels contributes to tissue damage by producing peroxynitrite anion through its 
interaction with superoxide. Peroxynitrite is a powerful long-lived oxidant, 
which is known to cause acute inflammation and oedema (Salvemini et al,
1996).
In addition to NO, other free radicals produced by inflammatory cells include 
superoxide anion radical, hydrogen peroxide and the extremely reactive hydroxyl 
radicals. These free radicals are produced in anaerobic conditions and are known 
to play a key role in the aetiology of fibrosis (Cerutti et al, 1992). Superoxide 
anion induces inflammatory cells to degranulate and release mediators important
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in the development of fibrosis including TGF-beta and TNF-alpha (Gordon and 
Galli, 1994). Reactive oxygen intermediates (ROI), reactive nitrogen 
intermediates (RNI) and cytokines are frequent companions at sites of acute 
inflammation. A clear link exists between certain cytokines production and 
subsequent generation of ROI and RNI (Remick and Villarete, 1996). Recent 
data suggests ROI, RNI and NO not only act as an end-stage effector molecule, 
but also as an initiator of acute inflammation. For example ROI and RNI will 
upregulate IL-8 production specifically via other cytokines. In addition, nitric 
oxide synthesis inhibitors decrease the production of IL-8 in stimulated whole 
blood and fibroblasts and exogenously added ROI increasing IL-8 production by 
the same cells (Remick and Villarete, 1996).
TGF-beta is involved in stimulating extracellular matrix production and healing 
by fibrosis. Many cytokines (particularly IL-1 and TNF-alpha) stimulate 
production of nitric oxide from various cells. TGF-beta can also suppress the NO 
production by reducing iNOS expression (Vodovotz and Bogdan, 1994), Some 
cells demonstrating this suppression include macrophages, smooth muscle cells, 
endothelial cells, fibroblasts and mesangial cells (Vodovotz and Bogdan, 1994, 
Junquero et al, 1992; Finder et a l, 1995; Lavnikova and Laskin, 1995; Ikeda et 
al, 1994). The relationship of these interactions in Dupuytren’s tissue has not 
been established.
Recent evidence is accumulating that implicate nitric oxide as a secondary 
messenger in intracellular signal transduction pathways involved in triggering 
many cells, including inflammatory cells, to undergo apoptosis (Nishio et al.
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1996; Um et al, 1996; Shimaoka et al, 1995; Palluy and Rigand, 1996; Messmer 
et a l, 1996). This may offer another avenue of intervention once the exact 
mechanism is understood. Importantly, current pharmacological agents can 
control nitric oxide production.
78
1.10.7
Steroids
Steroids are the most potent and effective agents in controlling chronic 
inflammatory diseases (Barnes and Adcock, 1993). Steroids interact with a 
cytoplasmic receptor, part of a supergene family, present in almost all cells but in 
differing densities. The regulation of these receptors expression can be at the 
transcriptional, translational or post-translational stages, as seen in the down- 
regulation of steroid receptors in circulating monocytes and lymphocytes after 
steroid therapy (Wilckens, 1995).
Gene transcription
In responsive cells, steroids regulate transcription of certain target genes usually 
of 10-100 genes per cells (Owens et al,  1991). Within the nucleus the receptor 
forms a dhner and binds to the DNA at the glucocorticoid response elements 
(GREs). The receptor can promote or suppress transcription by steric hindrance 
or it can reduce mRNA stability (Barnes and Adcock, 1993).
Anti-inflammatory effects
Cytokines
Steroids decrease the transcription of cytokines e.g. IL-1, TNF-alpha,
Granulocyte macrophage colony stimulating factor (GM-CSF), IL-3, IL-4, IL-5, 
IL-6, IL-8. The mechanism involves GREs and reduced mRNA stability (Guyre
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et al, 1988). Steroids also block cytokines' effects in other ways, including by 
decreasing IL-2 receptors and inactivating transcription factors e.g. NFkB 
(Barnes and Adcock, 1993). Dexamethasone downregulates expression of IL-8 
mainly by decreasing mRNA stability. That is, they repress genes in conditions 
of stress (Standiford et al, 1992).
Nitric oxide
iNOS in macrophages is potently inhibited by steroids. The inhibitory effect is on 
the iNOS gene itself (Gilbert and Herschman, 1993).
Adhesion molecules
Steroid induced reduction of adhesion molecule expression is mainly secondary 
to reduced cytokine production e.g. IL-1 beta or TNF-alpha. However, they also 
have a direct inhibitory effect on expression of adhesion molecules at the level of 
gene transcription (Cronstein et a l,  1992). Aziz demonstrated this in endothelial 
cells, where dexamethasone reduced VCAM-1 expression (Aziz and Wakefield, 
1996).
Therapeutic implications for chronic inflammation
As all glucocorticoids bind to the same cytoplasmic receptor it is unlikely that 
more selective steroids will be developed. Their most important effect is the 
repression of genes encoding for cytokines and lipid mediator enzymes.
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Individual control of subsequent steps in the sequence of events may give more 
selective results without the potential side effects of steroids.
1.10.8
Steroid Effect On Inflammatory Components In Relation To Dupuytren’s 
Contracture
The histopathology of Dupuytren’s disease has been documented as already 
stated previously (Meyerding et a l, 1941, Luck, 1959). In addition to the 
myofibroblasts from the nodule itself (Gabbiano and Majno, 1972; Iwasaki et al, 
1984; Scürch et a l, 1992; Azzarone et a l, 1983), clusters of macrophages and T 
lymphocytes have been observed in Dupuytren’s tissue (Baird et al., 1993a). 
These inflammatory cells have been demonstrated to produce a spectrum of 
cytokines (Baird, 1993b), which regulate migration, proliferation, and 
contracture of Dupuytren’s myofibroblasts (Baird, 1994). These cytokines 
include bFGF, IL-1 alpha / beta, TGF-beta 1 & 2, TNF-alpha, IL-8.
Some clinicians had noted the effect of locally injected steroid could sometimes 
halt the progressive proliferation of Dupuytren’s nodules macroscopically and 
indeed cause them to regress in size (Ketchum et a l, 1972). Therefore, the effect 
of preoperatively locally injected steroid on the above interrelated extracellular 
matrix protein, adhesion molecule, integrin and cytokines required clarification.
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1.10.9
Steroid Induced Apoptosis In Dupnytren’s Disease
In normal granulation tissue myofibroblasts disappear by apoptosis. In excessive 
scarring tissue myofibroblasts persist (Desmouliere, 1995). This differing 
behaviour of myofibroblasts is dependent on environmental factors controlled by 
inflammatoiy cells.
Thus chronic inflammatory conditions depend on the capacity to inhibit an 
intrinsic suicide pathway in these inflammatory cells or in the myofibroblasts. In 
inflammatory tissue undergoing normal resolution a decrease would be expected 
in monocyte population by apoptosis and in subsequent cytokine production. For 
example, the normal resolution of muscle inflammation macrophages undergo 
such selective apoptosis (Tidball and St Pierre, 1996)
Regulation of monocyte and lymphocyte apoptosis
Cellular Adherence
Collagen, fibronectin and laminin increase monocyte survival by blocking 
apoptosis (Mangan et a l, 1993), The extracellular matrix glycoprotein CSl 
fibronectin is present in large amounts in Dupuytren's tissue and is a natural 
ligand for monocytes.
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Chemotactic factors
Chemotactic factors including TGF-beta 1 are extremely potent at recruiting 
monocytes to sites of inflammation, although it appears that additional activation 
is required to block apoptosis. TGF-beta stimulates IL-1 production but also IL-1 
receptor antagonist protein and thus has little net effect. The pro-inflammatoiy 
cytokines, IL-1 and tumour necrosis factor alpha are independently able to inhibit 
monocyte apoptosis (Mangan et a l, 1993; Maier et a l, 1996), Both IL-1 and 
TNF-alpha are expressed by Dupuytren's cells (Baird et a l, 1993b).
Steroids
Steroids have been shown to induce inflammatory cell depletion by apoptosis in 
the intestine of rats (Soda et a l, 1993) and augment T cell apoptosis in 
inflammatory lesions of the peripheral nervous system in the rat (Zettl et al, 
1995). This may be an augmentation to their anti-inflammatory effects mediated 
by direct inflammatory cell apoptosis. The subsequent down-regulation of 
growth factors and cytokines itself may induce apoptosis indirectly as another 
mechanism of effect.
There may well be a direct effect of steroids on fibroblasts and other non­
inflammatory cells as well. For example, Lutton demonstrated rat osteoclasts 
underwent morphological changes resembling apoptosis after 2-4 hours of 
exposure to dexamethasone and corticosteroid (Lutton et a l, 1996).
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1.11
Hypothesis
Dupuyti'en’s disease is a chronic inflammatory disease characterised by the 
presence of increased levels of pro-inflammatory cells and growth factors. This is 
theorised as due to the persistence of inflammatory cells, which normally would 
undergo apoptosis. The aim of this work was to record the effect of steroids on 
Dupuytren’s tissue pro-inflammatory cytokines, growth factors, extracellular 
matrix and the rate of apoptosis of inflammatory cells and fibroblasts. 
Understanding the individual pathways involved may allow more accurate 
targeting of therapeutic intervention to prevent the subsequent fibrosis. This may 
have relevance to many inflammatory conditions that lead to fibrosis.
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2.1
PATIENTS
The patients were all taken from referrals to the hand clinic of the Western 
Infirmary, Glasgow, Scotland. They represented a typical cross section of the 
West of Scotland population. All patients entered were primary presentations and 
had not undergone previous surgery. Ethical permission had been previously 
granted for the study on pro-inflammatory cytokines by Mr Baird in the early 
1990’s. As all sample material would normally be disposed of, no results were 
made aware to the patient and the treatment of nodules with steroids is a 
recognised management (Ketchum et a l, 1974), there was no objection from the 
local ethical committee at that time. All patients gave consent for the use of their 
tissue for this study. The consultant, the specialist hand registrar, or myself 
performed all the surgery.
The patients were studied as follows. The immunohistochemistry study of 
inflammatory cytokines in Dupuytren’s tissue and the effect of steroids were 
studied in 20 patients with Dupuytren’s disease undergoing routine fasciectomy 
and 4 patients undergoing routine carpal tunnel decompression.
The immunohistochemistry study of the extracellular matrix and adhesion factors 
in Dupuytren’s tissue and the effects of steroids were studied in 30 patients and 
the same control tissue was used from the carpal tunnel decompressions.
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Thirdly, the effect of steroids on proliferation and apoptosis in Dupuytren’s 
tissue was studied by immunohistochemistry in 32 patients.
Finally, flow cytometry was used to study the effect of steroids on apoptosis of 
cultured Dupuytren’s cells, cultured palmar fascia cells and of cultured fascia lata 
cells. 6 patients undergoing fasciectomy had cultures grown from the excised 
tissue, 6 patients undergoing routine carpal tunnel decompression had cultures 
grown from excised palmar fascia and finally 2 patients undergoing fractured 
neck of femur surgery had cultures grown from samples of fascia lata.
In the study of steroid changes on the inflammatory cytokines 20 patients were 
used. Ten Dupuytren’s patients (7 men and 3 women) were entered into the non­
steroid treated group and 10 Dupuytren’s patients (8 men and 2 women) into the 
group preoperatively injected with steroid. The average age of the untreated 
group was 47 years +/-11 years SD (29 to 63 years range) and was comparable 
with the steroid treated group age average of 52 years +/-13 years SD (36 years 
to 67 years range). The patient group treated with steroid had 20mg 
depomedrone, in a volume of 0.5ml, injected into the perinodular area of the 
palm at five days prior to operation at the pre-operative assessment clinic. All 
patients were at a comparable stage of Dupuytren’s contracture and activity. 
Surgery was performed routinely under regional anaesthesia and tourniquet 
control. 4 patients undergoing routine carpal tunnel decompression had a 
representative sample o f palmar fascia excised. Surgery was performed under 
identical conditions, again with regional anaesthesia and tourniquet control.
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Samples of excised Dupuytren's tissue and palmar fascia control tissue were 
placed in 10% neutral buffered formalin solution.
In the study of steroid changes on the extracellular matrix and adhesion factors 
30 patients were used. 20 Dupuytren’s patients (17 men and 3 women) were 
entered into the non-steroid treated group and 10 Dupuytren’s patients (8 men 
and 2 women) into the group preoperatively injected with steroid. The average 
age of the non-steroid treated group was 58 years +/-14 years SD (40 to 77 
years’ range) and was comparable with the steroid treated group age average of 
54 years +/-16 years SD (31 years to 75 years range).
For the study of steroid effect on apoptosis in tissue, 32 patients undergoing 
fasciectomy were studied in two groups of 16. One group of 16 Dupuytren’s 
patients (14 men and 2 women) were entered into the non-steroid treated group 
and the other group.of 16 Dupuytren’s patients (14 men and 2 women) into the 
group preoperatively injected with steroid. The average age of the untreated 
group was 54 years +/-15 years SD (42 to 70 years range) and was comparable 
with the steroid treated group age average of 57 years +/-18 years SD (35 years 
to 75 years range). The patient group treated with steroid had 20mg 
depomedrone, in a volume 0.5ml, injected into the perinodular area of the palm 
five days prior to operation at the pre-operative assessment clinic. All patients 
were at a comparable stage of Dupuytren’s contracture and activity clinically, 
and on subsequent histological assessment. Surgery was performed routinely 
under regional anaesthesia and tourniquet control. Samples of excised 
Dupuytren's tissue were placed in 10% neutral buffered formalin solution.
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Tissues for culture experiments were collected as follows.Tissue from 6 patients 
undergoing palmar fasciectomy for Dupuytren's disease was used for culture 
experiments. The tissue was placed in a transport medium immediately after 
excision and processed within the hour. Again for culture experiments, 6 patients 
undergoing routine carpal tunnel decompression had a representative sample of 
pahnar fascia excised. Surgery was performed under identical conditions, again 
with regional anaesthesia and tourniquet control. None of these patients had 
received preoperative steroid injections. Fascia lata samples were obtained at 
Wound clôSüfé fi'Oni two pâfîéhts imdérgôitig routine dÿhàhiic-hip screw fixation 
of fractured necks of femur. Again, no preoperative injections at the site of 
operation had been performed. The fascia lata samples were used for culture 
experiments only and were again stored in transport medium (Hanks medium 
supplemented with 2% foetal calf serum (FCS) and antibiotics) and identically 
processed prior to culture. No patients in any group had been receiving oral or 
parental steroids.
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2.2
IMMÜNOHiSTOCHËMÏSTRY
I performed all histological preparations. The analysis of sections was 
independently performed by one of the laboratory technicians and verified by 
myself.
Samples of Dupuytren's and control tissue had been collected at the time of 
surgery in 10% formalin. All subsequent procedures were carried out at room 
temperature unless otherwise stated. The samples were dehydrated sequentially 
through a gradation of alcohol and histoclear solutions prior to embedding in 
paraffin wax. The tissue blocks were then cut and 7pm sections mounted onto 3- 
Aminopropyl triethoxy-silane (APES) coated slides. Immunohistochemistry was 
performed on the sections by the sandwich technique employing the avidin-biotin 
alkaline phosphatase complex. Sections were dewaxed with histoclear, 
rehydrated in graded alcohol solutions to 0.05 M Tris Buffer (pH7.2), and then 
pretreated with trypsin (Sigma, LOmg dissolved in 1ml of deionised water) for 
15 minutes at 37°C. After 3 washes with TBS pH 7.2 the sections were incubated 
with primary antibody for 1 hour. The sections were then incubated with 
biotinylated secondary antibody (Sigma Immuno Chemicals; 1:60 dilution) for 
45 minutes followed by 3 washes with TBS pH 7.2 and then finally incubation 
with extravidin alkaline phosphatase (Sigma Immuno Chemicals; 1:400 dilution) 
took place for 45 minutes with final 3 washes with TBS pH 7.2. Bound alkaline 
phosphatase was visualised using BCIP/NBT (5-Bromo-4-Chloro-Indolyl 
Phosphate / Kitro Blue Tétrazolium) at room temperature until visualisation was
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complete or background changes were evident. This gave a bluish / black / brown 
colour depending on the intensity of reaction. Alternatively, bound alkaline 
phosphatase was visualised using Fast Red TR/Napthol AS-MX Phosphate (4- 
Chloro-2-methylbenzenediazonium/3-Hydroxy-2-naphthoic acid 2,4- 
dimethylanilide phosphate), producingan intense red stain. The section was 
placed in distilled water to stop this reaction and then counter-stained with 
(0.5%) neutral red. Control negative sections were run without primary antibody. 
The sections were then mounted in 50% glycerol solution with a coverslip.
The antibodies used were rabbit anti human TNF-alpha (R&D systems; 1:60 
dilution), sheep anti human IL-1 alpha (R&D systems; 1:60 dilution), sheep anti 
human IL-1 beta (R&D systems; 1:60 dilution), rabbit anti human IL-4 (R&D 
systems; 1:60 dilution), goat anti human IL-6 (R&D systems; 1:60 dilution), goat 
anti human IL-8 (R&D systems; 1:50 dilution), goat anti human bFGF (R&D 
systems; 1:6p dilution),.mouse antlhuman.CSl fibronectin(Chcmicon; 1:100 
dilution), goat antihuman VGAM-1(R&D systems; 1:200 dilution), mouse anti 
human VL A-4 (alpha 4 beta. 1 integrin) (Serotec;. 1:100 dilution),. andLchicken 
anti human TGF-beta 1 and 2 (R&D systems, 1:60 dilution), Lewis Y (Sigma 
1:60; dilution) and.Ki 67 (DAKD; 1:60 dilution) antigen markers for apoptosis 
and proliferation respectively.
Ki67 is a nuclear protein, which is expressed in the proliferating cells during late 
G1-, S-, M-, and G2-phases ofthe cell cycle, while cells in the GO (quiescent) 
phase are negative for this protein (Rose ef «/., 1994). Lewis Y antibody 
recognises a carbohydrate identified as a marker of specific types of cell and
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specific stages of differentiation. Expression of Lewis Y has been shown to 
correlate closely with the process o f apoptosis, but not with cell proliferation or 
necrosis (Hiraishi et a l, 1993).
Counting of immunostained cells and areas of diffuse matrix staining was 
performed over 3 eonsecutive sections and 5 random areas (at times 25 
magnification) for each patient sample. For the cell numbers allocated these were 
entered into Excel worksheets and where appropriate statistical analysis was 
performed by means of the Mann-Whitney U test for non-parametric data. Where 
the areas on the histological sections were assessed for background immuno- 
reactivity this was done by allocating the degree of immuno-reactivity for that 
particular field area, namely as: +++ diffuse strong reactivity; ++ strong 
immunoreactivity restricted to cellular areas; - no immunoreactivity.
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2.3
CELL CULTURE FOR APOPTOSIS ANALYSIS BY FLOW 
CYTOMETRY
The sterile tissue sample was transported in Hanks medium supplemented with 
2% foetal calf serum (FCS) and antibiotics. As soon as possible after surgery 
(within 2 hours) the tissue sample was washed three times with Dulbecco’s 
calcium and magnesium fi*ee phosphate bufferered saline (PBS, Gibco). The 
tissue was then cut into Imm^ fragments in a large petri dish containing 
Üulbecco’s PBS. The tissue fragments were transferred to a pre-weighed 
Universal container, spun down at 2000 revolutions per minute (RPM) for 5 
minutes at room temp and the supernatant discarded. The tissue was then washed 
3 times with PBS, the final wash carefully removed and the weight of tissue 
noted. 2 to 4 g of wet tissue was used per 25ml of collagenase / 
Deoxyribonuclease 1 (DNase). Tissue fragments were washed into a 100ml 
Erlenmeyer flask (conical flask) with the dissociation mixture. The tissue was 
digested for 3.5 hours at 37^C in a shaking water bath with 25ml Hanks balanced 
salt solution containing 0.1% collagenase and 0.01% DNase (DN-25, Sigma).
Cells and debris were removed by transferring the sample to a universal 
container and centrifuged at 400 x g at room temperature for 10 minutes, 
supernatant then discarded. The cells and tissue washed into the same conical 
flask used for the first incubation with 50ml Dulbecco’s PBS containing 0.05% 
Typsin (Type 3, Sigma) and 0.02% EDTA and a further incubation at 37^C in a 
shaking water bath carried out
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The cells were separated from the undigested residue by allowing the residue to 
settle for 5 minutes then filtering the supernatant through sterile gauze, the 
remaining residue then washed with DMEM + 10% FCS and then filtered 
through the gauze. After dilution with DMEM+ 10% FCS, 1ml samples of 1 x 
10  ^cells were plated in 35mm^ Nunc petri dishes and placed into a CO2 
incubator at 5% CO2 , 37% in a moist atmosphere.
The palmar fascia cells were much slower to grow, taking up to a month to reach 
a state where the cells had covered most of the petri dish base. Cells were always 
harvested just before they completely covered the petri dish base, to avoid the 
subsequent effect of contact inhibition on growth (sub-confluence). The fascia 
lata fibroblast cultures were quicker but still not as fast at replicating as the 
Dupuytren’s cells. The 6 individual palmar fascia cells cultures were added 
together into 2 cultures just prior to analysis in order to give sufficient cells for 
FACS analysis. This was not necessary for the fascia lata cultures
Once sub-confluence was reached, half the cultures of cells from Dupuytren's 
tissue, palmar fascia tissue and fascia tissue had soluble methyl prednisilone (10'^ 
M) added. 14 hours later all these cell samples were harvested.
An apoptosis detection kit (R & D  systems) was used to quantitatively determine 
the percentage of cells undergoing apoptosis by virtue of their ability to bind 
annexin V and exclude propidium iodide. The test is based on the observation 
that soon after the initiation of apoptosis, most cell types translocate 
phosphatidylserine from the inner surface of the plasma membrane to the cell
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surface (Martin et a l, 1995). Once on the cell surface, phosphatidylserine can be 
easily detected by staining for Annexin V, which has a strong, natural affinity for 
phosphatidylserine (Andree et al, 1990).
Harvested cells were collected by trypsinisation and suspended in Ix binding 
buffer (R & D  annexin V kit) at a concentration of Ix 10® cells/ml.
Harvesting bv trvpsinisation of cell monolavers
1 Decant off medium (Dulbecoo ’ s modification of Eagle ’ s medium +
10 % foetal calf serum and antibiotics).
2 Wash cells with phoshate buffered saline (PBS) without Calcium and 
Magnesium - Decant off.
3 Add 0.02% EDTA solution sufficient to cover cells and leave at room 
temperature for 30 seconds and decant off.
4 Add 0.02% EDTA / 0.05% trypsin solution, sufficient to cover cells, 
leave at room temperatures for 30 seconds and decant off
5 Incubate cells at 37% until cells become detached.
6 As soon as cells become detached, resuspend in medium and harvest 
the cells by spinning at room temperature, 1000 revolutions per 
minute for 10 minutes on a MSE super minor centrifuge.
7 Wash cells, resuspend in medium or buffer, making sure any clumps 
are broken up.
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The cells were washed with buffer solution and a Uypan blue exclusion test used 
to check the percentage of alive cells at this concentration.
100 u\ of these cells (1x10^ cells) were transferred to a 5ral tube. 10 mI of 
fluorescein-conjugated annexin V and 10 wl of propidium iodide (PI) reagent 
were added, and the mixture was gently vortexed and then incubated for 15 
minutes at 20-25®C (room temperature) in the dark. Following this incubation, 
and without further washing the cells of excess reagents, 400 m1 of Ix binding 
buffer were added. Three additional control tubes were also set up: a) unstained 
cells; b) cells stained with annexin V-fluorescein only; c) cells stained with PI 
only (Table 3).
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Table 3
Tubes (Sample lOOwl) PI (wl) AnnexinV (u\) Buffer (wl)
1 cells .... — 20
2 cells '-- — 20
3 cells 10 — 10
4 cells 10 — 10
5 cells — 10 10
6 cells — 10 10
7 cells 10 10 —
8 cells 10 10 —
9 Steroid treated cells 10 10 —
10 Steroid treated cells 10 10 —
The level of fluorescence was measured with the Lysis II programme on a 
Becton Dickinson FACScan flow cytometer (Figure 10). Dedicated software 
permitted statistical analysis of the data obtained. Purely annexin V binding cells 
were determined by gating of these cells and the ratio compared with and without 
steroid addition and taken as a level of apoptosis. This was expressed as a 
percentage of the total cell number. Statistical analysis was performed by the 
Mann-Whitney U test to compare the effect of steroids on the apoptosis ratio.
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Figure 10
Diagrammatic sketch of a flow cyometer. The flow cytometer was equipped with 
single 15mW argon laser emitting light at 488nm. The FITC detector detects 
fluorescence data generated from the fluorescein-labelled annexin V labelled cells 
(usually FLl) and propidium iodide labelled cells are monitored by the detector 
reserved for phycoerythrin emission (usually FL2). The FITC emission light was 
measured by filtering through a narrow-band green filter (530 nm).
98
iK tU tV .Y .*
u
99
2.4
STEROIDS
The steroid used in the patients receiving preoperative palmar injections was 
depo-medroiie 40 mg in a 1ml volume. For the culture experiments this steroid 
preparation would not have been miscible with the medium to give a clear view 
of the cells. Therefore, solu-medrone (Upjohn) was used at an equivalent 
therapeutic concentration for this steroid type of 10"^  M. This concentration of 
10’^  M had induced observable changes consistent with apoptosis in previous cell 
culture studies at this department. The solu-medrone had induced characteristic 
changes including intense cell surface activity, cell shrinkage aud subsequent 
condensation of ehi'omatin in a crescent shaped manner along the nuclear 
envelope. 49.651 mg were dissolved in 1 ml of medium to give a 0.1 M solution 
and this was further diluted to give 10'  ^M solution.
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MATERIALS
Crude bacterial Collagenase Type 1, Sigma Chemical Company 
Nunc Petri dishes^ Gibco Europe 
Tiypsin, Sigma
Content Trypsin I.Omg/tabley
Calcium Chloride 0.6mg/tabiet 
Tris Buffer
One tablet, dissolved in I ml-delonised water yields Img/ml trypsin, 4mM 
CaCli in 200mM: Tris, pH 7.7 a t l fC
BCIP/NBT (5-Bromo-4-Chloro4ndoIyl Phosphate / Nitro Blue Tétrazolium)^ 
Sigma
One tablet, dissolved in 10ml of deionised water
Fast Red TR/Napthol AS MX Phosphate (4-Ghloro-2-methyibenzenediazonium 
/3-Hydroxy-2-naphthoic acid 2,4-dimethylahilide phosphate). Sigma 
One tablet dissolved in 1ml of deionised water
Microscope
Axioplan 2 microscope, Carl Zeiss Ltd 
SLR 35 mm Camera, Yashica
Dulbecco’s modified Eagles culture medium
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Culture Medium
Dulbecco’s modified Eagles medium (DMEM, Gibco)
Foetal calf serum (FCS, Heat and pH inactivated, Gibco)
100 units / ml : 100/^1 /ml Penicillin : Streptomycin (Gibco)
DMEM 500ml
FCS 50ml
Penicillin : Streptomycin 5ml 10000 units / ml : 10000 mg / ml 
Stored sterile at 4 °C for no more than 1 month.
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Dissociation Médium
0.1% collagenase (Type 1, Sigma)
0.01% Deoxyribonuclease 1 (DN -  25, Sigma)
29mM Hepes (Gibco)
100 units / ml : 100^1 /ml Penicillin : Streptomycin (Gibco)
Hanks balanced salt solution (HBSS, Gibco)
100ml
Collagenase 0.1 g
Deoxyribonuclease 0.01 g
Hepes 2mIIM HEPES
Penicillin : Streptomycin 1ml 10000 units/ml : lOGGOmg /ml
HBSS I OmI (10 X Concentration)
Make to 100ml with deionised water and sterilise by filtration through a O.lfztsx 
pore size filter.
Trvnsin/EDTA
0.05% Tiypsih (Type iri, Sigma)
0.02% Ethylenediaminetetra-aeetic acid (Disodium salt, EDTA)
Phosphate buffered saline (PBS, Gibco)
1 X
Trypsin 0.1 g
EDTA 0.04g
PBS 20 ml (10 X concentration)
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Make to 200ml With deiohised water aftd sterilise by filtration through a 0.2/fm 
pore filter and store in deep fi*eeze.
Hanks Transport Medium
Sodium bicarbonate (Gibco)
Hanks balanced salt solution (HBSS, Gibco)
Foetal calf serum (FCS, Gibco)
250 units / ml : 250/ig / ml Penicillin : Streptomycin (Gibco)
Sodium bicarbonate 70mg
HBSS 20ml 10 x conentration
FCS 4ml (heat and pH inactivated)*
Penicillin ; Streptomycin 5ml 100000 / ml ; lOOOOOmg / ml
*Heat to inactivate complement. pH to inactivate aIpha-2-macrogIobulin, this is 
necessary for collagenase estimations as a-2-macroglobüim binds irreversibly 
with collagenase
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CHAPTERS
RESULTS
3.1 Immunohistochemistrv - Pro-inflammatorv cytokines in Dupnvtren’s 
disease and the effect after steroids
3.2 Immunohistochemistrv - matrix and adhesion factors and the effect 
of steroids
3.2 Immunohistochemistrv - anoptosis and proliferation and the effect 
of steroids
3.3 Flow Cvtometrv Anaivsis - apoptosis in cell cultures and the effect of 
steroids
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3.1
Immunohistochemistrv for Pro-Inflammatory Cytokines
The results of immunological studies on Dupuytrens control tissue samples were 
analysed according to the histological areas of: (1) fibrofatty tissue surrounding 
the Dupuytren’s nodule, (2) the nodule itself and (3) cord tissue.
Histology of Fibrofatty Tissue Surrounding The Nodules
This perinodular tissue histologically demonstrated the presence of a chronic 
inflammatory reaction. The unaffected subcutaneous fat gave way to vascular 
connective tissue containing many small blood vessels and an inflammatory 
infiltrate composed chiefly of lymphocytes and occassional mast cells. The 
smaller blood vessels lay within a stroma of disorientated and loosely woven 
collagenous connective tissue. Within this stroma there were well-defined 
bundles of arterioles and venules in close proximity to collections of 
lymphocytes (Figure 11). These clusters of lymphocytes occurred only within the 
perinodular tissue and did not occur within the nodules or in the cord tissue. 
There was little evidence of other types of inflammatory cells in these tissues 
other than occasional macrophages and mast cells. The arteriolar walls were 
often thickened with smooth muscle hypertrophy and the capillary endothelium 
was frequently swollen.
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Figure 11
Section of Dupuytren’s tissue stained by immuno-histochemistry for TNF-alpha 
antibody and visualised with Fast Red TR/Napthol AS-MX Phosphate (Intense red 
stain positive). The general histology of the perinodular tissue (x 25 magnification) is 
demonstrated. The unaffected subcutaneous fat gives way to vascular connective 
tissue containing many small blood vessels and inflammatory cells. 2 pockets of 
lymphocytes can be seen. The arterioles walls were thickened.
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Immunohistochemistrv of Fibrofatty Tissue Surrounding The Nodules
IL-1, TNF-alpha and IL-8 were all localised in similar areas of endothelium 
and in inflammatory cells (Figures 12,13,14). Staining of endothelium was 
strong in some areas but weak in others. In general, those microvessels, 
which lay in close proximity to lymphoid follicles, stained positively for all 
three cytokines, whereas staining was absent in blood vessels with no 
adjacent inflammatory cells, despite these vessels often being narrowed by 
smooth muscle proliferation. Most of the positive staining cells were present 
around the margins of the lymphoid follicles, with some identified within the 
small blood vessels. Small numbers of positively staining lymphocytes were 
present within the connective tissue close to the blood vessels. Occasionally, 
the extracellular matrix showed slight staining for all three cytokines but in 
general was negative for IL-1, TNF-alpha and 11-8 in this area.
lL-4 stained very positively in inflammatory cells in general and lymphocytes in 
particular (Figure 15), lnterleukin-6 was present in some small capillaries but in 
general the main blood vessels were negative (Figure 15). bFGF was strongly 
staining in small and slightly larger blood vessel’s endothelium (Figure 16).
Histology And Immunohistochemistrv of Nodules
The nodules were highly cellular and composed of fibroblasts arranged in tightly 
packed whorls containing substantial numbers of capillaries. The nodules again 
stained positive for lL-1, TNF-alpha and IL-8, this time demonstrating both
109
Figure 12
Section of Dupuytren’s tissue stained by immuno-histochemistry for TNF-alpha 
antibody and visualised with Fast Red TR/Napthol AS-MX Phosphate (Intense red 
stain positive). TNF-alpha distribution demonstrated in the perinodular of 
Dupuytren’s tissue (x 40 magnification). There is strong staining of the endothelium 
around the margin and of individual inflammatory cells.
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Figure 13
Section of Dupuytren’s tissue stained by immuno-histochemistiy for IL-1 antibody 
and visualised with Fast Red TR/Napthol AS-MX Phosphate (Intense red stain 
positive). IL-1 demonstrated in the perinodular area (x 40 magnification). There is 
strong staining of the endothelium around the margin and some staining of individual 
inflammatory cells.
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Figure 14
Section of Dupuytren’s tissue stained by immuno-histochemistry for IL-8 antibody 
and visualised with Fast Red TR/Napthol AS-MX Phosphate (Intense red stain 
positive). IL-8 demonstrated in the peri-nodular area (x 10 magnification). There is 
strong staining of the endothelium around the margin but in general, the distribution 
was not as widespread as for TNF-alpha and IL-I.
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Figure IS
Section of Dupuytren’s tissue stained by immuno-histochemistry for IL-4 and IL-6 
antibodies and visualised with Fast Red TR/Napthol AS-MX Phosphate (Intense red 
stain positive). IL-4 and IL-6 demonstrated in the perinodular area. Top figure 
demonstrates IL-4 stained quite positively for inflammatory cells in general (x 25 
magnification). Bottom figure demonstrates IL-6 was present in the small capillaries 
of the fibro-fatty area of the tissue (x 10 magnification).
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Figure 16
Section of Dupuytren’s tissue stained by immuno-histochemistry for bFGF antibody 
and visualised with Fast Red TR/Napthol AS-MX Phosphate (Intense red stain 
positive). bFGF demonstrated in the perinodular area (x 25 magnification). bFGF is 
present in the blood vessel endothelium.
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intracellular and intercellular staining (Figures 17,18,19). Again, the distribution 
was very similar for all three. The fibroblasts, the capillary endothelium and the 
extracellular matrix all stained strongly. IL-8 distribution was less homogenous 
than IL-1 and TNF-alpha. Although IL-8 was invariably present in mononuclear 
inflammatory cells, it was sometimes confined in a few distinct clumps of 
fibroblasts within the nodule. It was apparent from the sections that each nodule 
comprised a number of positively staining mini-nodules separated by fibro- 
cellular septae, which showed no cytokine staining. The capillaries, which passed 
through these septae, showed positive staining for these pro-inflammatory 
cytokines. The strongest staining within the nodules was found in the capillary 
endothelium and lymphocytes and macrophages, which were present in small 
numbers. Some lymphocytes were visualised within the capillaries and 
occasionally could be observed adherent to the endothelium while others were 
present in small cuffs just outside the capillaries. Occasional positively staining 
macrophages were also observed in the tissues.
IL-4 and IL-6 were scantily present within the actual nodule itself (Figure 20), 
IL-4 stained positively in occasional inflammatory cells, mainly macrophages, 
and IL-6 was generally present in some small capillaries. bFGF stained in some 
Dupuytren’s fibroblasts, mainly in the centre of the nodules (Figure 21).
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Figure 17
Section of Dupuytren’s tissue stained by immuno-histochemistry for TNF-alpha and 
visualised with Fast Red TR/Napthol AS-MX Phosphate (Intense red stain positive). 
TNF-alpha demonstrated in the nodule. TNF-alpha is present with both intracellular 
and intercellular staining with a diffuse pattern present within defined areas of the 
nodule, (a) The staining was quite homogenous within the mini-nodules in the larger 
nodule (x 25 Magnification), (b) Some individual fibroblasts also stained strongly for 
TNF-alpha (x 40 Magnification), (c) TNF-alpha stained strongest for sweat glands 
and blood vessels towards the edge of the nodule (x 10 Magnification).
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Figure 18
Section of Dupuytren’s tissue stained by immuno-histochemistiy for IL-1 antibody 
and visualised with Fast Red TR/NapthoI AS-MX Phosphate (Intense red stain 
positive). IL-1 demonstrated in the nodule, (a) and (b) IL-1 is present with both 
intracellular and intercellular staining, often with a diffuse pattern present, or within 
well defined areas of the nodule and is present in the blood vessels passing through 
the nodule (x 25 Magnification). IL-1 positively stained the blood vessels penetrating 
via septa into the nodule (x 25 magnification), (c) IL-1 stained positively for the 
occasional inflammatory cell present within the nodule (x 40 Magnification).
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Figure 19
Section of Dupuytren’s tissue stained by immuno-histochemistry for IL-8 antibody 
and visualised with Fast Red TR/Napthol AS-MX Phosphate (Intense red stain 
positive). IL-8 demonstrated in the nodule edge. IL-8 is present with both intracellular 
and intercellular staining, but with a more distinct focus of individual areas of positive 
staining than IL-1 or TNF-alpha. (a) IL-8 stained positively around some individual 
fibroblast (x 10 magnification) and (b) also the blood vessels towards the edge of the 
nodule.
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Figure 20
Section of Dupuytren’s tissue stained by immuno-histochemistry for IL-4 and IL-6 
antibodies and visualised with Fast Red TR/Napthol AS-MX Phosphate (Intense red 
stain positive). IL-4 and IL-6 demonstrated in the nodule, (a) IL-4 stained the 
fibroblasts and occasional inflammatory cell (xlO magnification) but (b) IL-6 was 
generally more present in the smaller blood vessels in the septae running between and 
through the nodules.
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Figure 21
Section of Dnpnytren’s tissue stained by immuno-histochemistiy for bFGF antibody 
and visualised with Fast Red TR/Napthol AS-MX Phosphate (Intense red stain 
positive). bFGF demonstrated in the nodule (x 25 magnification). bFGF stained the 
occasional fibroblast in the centre of the nodule and was present in some of the blood 
vessel endothelium.
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Histology and Immunohistochemistrv of Cord Tissue
The cord tissue was of uniform appearance. They comprised dense longitudinally 
orientated bundles of collagen interspersed with thin elongated fibroblasts. Very 
few blood vessels were present either within the cord or in the adjacent tissues. 
Inflammatory cells were conspicuous by their absence. Staining for pro- 
inflammatory cytokines was absent within the cords.
Histology and Immunohistochemistrv of Control Palmar Fascia Tissue
This tissue was almost identical histologically to cord tissue (Figure 22) and was 
almost completely devoid of any immuno-staining for pro-inflammatory 
cytokines.
Results of Preoperative Steroid Injections on the Immunohistocemistrv of all 
areas of Dupuvtren’s tisssue
The pre-operatively treated Dupuytren’s tissue showed an almost complete loss 
of any immuno-histochemical staining for pro-inflammatory cytokines. There 
was a very weak response for TNF-alpha and IL-8 in a few small perindular 
areas in 2 specimens only (Figure 23).
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Figure 22
Section of Palmar Fascia Tissue stained by van Gieson method for elastin fibres (x 10 
magnification). The tissue is very similar to cord tissue with regular fascicles of 
collagen and a low cell density. All sections were almost completely devoid of 
positive staining for pro-inflammatoiy cytokines.
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Figure 23
Section of Fibro-fatty area of Dupuytren’s tissue preoperatively treated with steroids. 
Stained by immuno-histochemistry for IL-8 antibody and visualised with Fast Red 
TR/Napthol AS-MX Phosphate (Intense red stain positive). Only one section 
demonstrated a very weak staining for IL-8 around inflammatory cells (x 25 
Magnification).
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TABLE 4
Immuno-Histocheiïiistrv Staining for II I. II-4.11-6. II-8. TNF-alpha. bFBF 
in Sections of Dupuvtren’s Tissue, with and without Pre-Operative Steroid 
Treatment, and in Sections of Palmar Fascia
IL-1 IL-4 IL-6 IL-8 TNF-alpha bFGF
CONTROL
DUPUYTREN’S ++ ++ -M- +♦
TISSUE (N -10)
STEROID TREATED
DUPUYTREN'S - - - - -
TISSUE (N=10)
PALMAR
FASCIA - - - -
TISSUE (N=4)
Presence o f Il-l, 11-4,11-6,11-8, TNF-alpha, bFBF in nodular tissue and fibrofatty 
tissue surrounding the nodules in both control and pre-operatively steroid treated 
Dupuytren’s tissue, and for palmar fascia sections, analysed by immuno- 
histochemistry, and summarised in Table 4. The results represent the average of 
5 independent fields at times 25 magnification. As the areas on the histological 
sections were assessed for background immunoreactivity this was done by 
allocating the degree o f immunoreactivity for that particular field area, namely 
as: -H- diffuse strong reactivity; + strong immunoreactivity restricted to cellular 
areas; - no immunoreactivity.
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3.2
Matrix and Adhesion Factors in Pupuvtren^s Tissue and The Effects of 
Pre-operative Steroids Inicctions
Fibrofatty tissue surrounding the nodules
The endothelium of the majority of blood vessels in this perinodular area had 
considerable positive staining for VCAM-1 (Figure 24). Very few cells stained 
positively for VCAM-1 other than these endothelial cells. CSl sequence of 
fibronectin stained positively for some of these blood vessels, both on the 
endothelium and around the arterioles in the loosely woven collagenous 
connective tissue (Figure 25). a4pl integrin expressing cells were abundant in 
the blood vessels and in the peri-vascular areas corresponding to areas where 
VCAM-1 stained positively for the endothelium of blood vessels (Figure 26). 
Finally TGF-beta 1 and 2 stained positively around the inflammatory cells in a 
perivascular relationship (Figure 27) that appeared to be in a similar distribution 
with the expression of CSl sequence of fibronectin (Figure 28).
Nodules
There was little in the way of VCAM-1 expression within the actual nodule, 
other than by the some of the larger capillary vessels penetrating between the 
nodules. CSl sequence of fibronectin stained quite positively for many of these 
blood vessels passing in between the smaller nodules. In addition, there was 
positive staining around the active myofibroblasts, principally at the peripheiy of
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Figure 24
Section of Dupnytren’s tissue stained by immuno-histochemistry for VCAM-1 
and visualised with BCIP/NBT (5-Bromo-4-Chloro-Indolyl Phosphate / Nitro 
Blue Tétrazolium). Top left section (x 10 magnification) stained endothelial cells 
positively (dark purple) in the blood vessels at the peri-nodular and peripheral 
nodule tissue. The other sections, at higher magnification (Top right and bottom 
left at X 25 magnification and bottom right at x 40 magnification), demonstrated 
endothelial staining for VCAM-1 in the blood vessel (dark purple) at the 
peripheral nodular areas and flbro-fatty tissue (counter-stain neutral red).
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Figure 25
Section of nodule area of Dupuytren’s tissue stained by immuno-histochemistry 
for CSl sequence of fibronectin and visualised with BCIP/NBT (5-Bromo-4- 
Chloro-Indolyl Phosphate / Nitro Blue Tétrazolium) with an intense purple stain 
(counter-stain neutral red). The bottom section demonstrated positive staining 
around the blood vessels at the periphery of active nodules and around the 
myofibroblasts themselves (x 25 magnification). The top section shows a closer 
view of the staining around and of the myofibroblasts themselves (x 40 
magnification).
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Figure 26
Section of Dupuytren’s tissue from around the edge of the nodule, stained by 
immuno-histochemistry for a4^1 integrin antibody and visualised with BCIP/NBT 
(5-Bromo-4-Chloro-Indolyl Phosphate / Nitro Blue Tétrazolium) with an intense 
purple stain. The sections, all at x 40 magnifications, demonstrated positively 
(dark purple) staining inflammatory cells around the blood vessels at the peri­
nodular and peripheral nodule tissue (counter-stain neutral red).
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Figure 27
Section of Dupuytren’s tissue stained by immuno-histochemistry for TGF-beta 
1& 2 antibody and visualised with BCIP/NBT (5 -Bromo-4-Chloro-Indoly 1 
Phosphate / Nitro Blue Tétrazolium) with an intense purple stain. TGF-beta 1& 2 
demonstrated at the edge of the nodule (Top section x 25 magnification and 
bottom X 10 magnification). Individual cells stained rather than a diffuse 
background of the extracellular matrix (counter-stain neutral red) at these 
particular areas.
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Figure 28
Sequential sections of Dupuytren’s tissue stained by immuno-histochemistry for 
TGF-beta 1& 2 antibodies (left 3 figures) and CSl sequence of fibronectin 
antibody (right 3 figures) and visualised with BCIP/NBT (5-Bromo-4-Chloro- 
Indolyl Phosphate / Nitro Blue Tétrazolium) with an intense purple stain. There 
was a similar distribution of intensity of staining demonstrated, particularly 
around the blood vessels in the peri-nodular tissue (x 10 magnification, 
counterstain neutral red).
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the nodules but also within small-localised swirls within some nodules (Figure 
25). a4j?l integrin expressing cells were relatively rarer within the nodule, 
mainly presenting as localised clumps within the nodule periphery. TGF-beta 1,2 
stained positively around some myofibroblasts in the nodule, and again this was 
similar to the distribution of the CSl-sequence of fibronectin.
Cord tissue
The cord tissue was notably absent of any VCAM-1 expression. Similarly, there 
was no staining for a4ySl integrin, and only very sparsely for CSl sequence of 
fibronectin or TGF-beta 1,2.
Control Palmar Fascia Tissue
The endothelium of palmar fascia blood vessels did not express VCAM-1 to any 
great extent. There were only a vety few scattered cells expressing a^p\ and 
these appeared relatively randomly distributed throughout the tissue sections.
CSl sequence of fibronectin and TGF-beta 1,2 showed only limited and random 
positive staining.
Steroids
The steroid-treated Dupuytren’s tissue did not express VCAM-1 strongly in the 
endothelium of the blood vessels and was much more akin to the palmar fascia 
immuno-staining pattern (Figure 29). aAp\ expressing cells were still present in a 
similar pattern of distribution but in reduced amounts. There was a generalised
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reduction in CSl sequence of fibronectin distribution, as also there was for TGF- 
beta 1,2 expression (Table 5).
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Figure 29
Sections of Dupuytren’s tissue preoperatively treated with an injection of methyl- 
prednisilone. Sections stained by immuno-histochemistry for VCAM-1 antibody 
and visualised with BCIP/NBT (5 -Bromo-4-Chloro-Indolyl Phosphate / Nitro 
Blue Tétrazolium) with an intense purple stain. The area is towards the periphery 
of the nodule and the surrounding fibro-fatty tissue, which would normally stain 
very positively for VCAM-1. The VCAM-1 expression has been reduced, as 
shown by the lack of purple staining of the endothelium of the blood vessels (x 10 
magnification, counter-stain neutral red).
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TABLE 5
Immunohistochemistrv Staining for VCAM-1. a4i^L TGF-ig and CSl 
Fibronectin Antigens in Sections of Dupuvtren’s Tissue, with and without 
Pre-Operative Steroid Treatment, and in Sections of Palmar Fascia
CELLULAR COUNTS 
PER FIELD AREA 
+/- 1 STANDARD 
DEVIATION
CSl Fibron#c#i
r lt>m .  ^ y * .  ^
-n"'
Mann-Whitney U test Level of 
Sign ificance
“ p<O.OS
* p<0.02
• p<0.01
VCAM-1, a4p\, TGF-beta and CSl sequence of fibronectin in the nodular tissue 
and fibrofatty tissue surrounding the nodules on both control and steroid treated 
Dupuytren’s tissue and for palmar fascia sections, was analysed by immuno- 
histochemistry, and summarised in Table 5. Counts were made from five fields
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(x25 magnification) from comparable areas of the nodule periphery. Three 
consecutive slide sections were counted for each patient sample.
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3.3
Immunohistochemistrv For Apoptosis And Proliferation In Sections Of 
Dupuytren’s Tissue. With And Without Pre-Operative Steroid Treatment
In sections of the control Dupuytren’s tissue, the cells staining positively for the 
Ki67 proliferation marker were predominately fibroblasts and were located at the 
periphery of many of the active nodules (Figure 30). In particular, the density 
was increased in the vascular perinodular fibrofatty layers. There were a few 
positively stained cells within the centre of nodules and very few within the 
cords leading away from the nodules. The Lewis Y marker for apoptosis stained 
in a similar pattern for fibroblasts in control Dupuytren’s tissue to the Ki67 
positive cells, but in marginally reduced frequency. A few macrophages and 
occasional lymphocyte also stained positively for Lewis Y.
In the steroid treated Dupuytren’s tissue the frequency of Ki67 expressing cells 
was generally decreased, and in particular the peripheral tissue normally 
associated with proliferation of fibroblasts showed the greatest reduction in 
expression of Ki67. Although there was an increase in the number of Lewis Y 
expressing fibroblasts at the periphery of the steroid treated Dupuytren’s tissue, 
the cells demonstrating the most marked increase in Lewis Y expression were 
macrophages. There was also a slight increase in the relative numbers of 
lymphocytes staining positively for Lewis Y. The changes in fi'equency of total 
cell markers are summarised (Table 6).
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Figure 30
Sections of Dupuytren’s tissue stained by immuno-histochemistry for Ki67 and 
Lewis Y antibodies and visualised with BCIP/NBT (5-Bromo-4-Chloro-Indolyl 
Phosphate / Nitro Blue Tétrazolium) with an intense purple stain. The top 2 
sections show Dupuytren’s tissue untreated with steroid and stained for Ki67 
antigen. A large number of cells positively stained at the periphery of active 
Dupuytren’s nodules (xlO magnification, counter-stain neutral red). The bottom 
two sections show Dupuytren’s tissue treated pre-operatively with steroid and 
stained for Lewis Y marker. The positively stained Lewis Y cells demonstrated 
were both macrophages and fibroblasts (x40 magnification on left and xlO 
magnification on right, counter-stain neutral red).
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TABLE 6
Immunohistochemistrv Staining for Lewis Y and Ki67 Antigens in Sections 
of Dupuvtren’s Tissue, with and without Pre-Operative Steroid Treatment
CELLULAR COUNTS 
PER FIELD AREA
i.'. K Ü7
CONTROL DUPUYTREN
n S S U E fN -1 6 )
STEROID T R ^ T E D 1.7 $ 4  Z t
)UPOYTREN TISSUE (N -16) ^ É t tÉ B
Mann-Whitney U test Level o f S ignificance
* P <0.05
Lewis Y and Ki67 antigens in the nodular tissue and fibro-fatty tissue 
surrounding the nodules on both control and steroid treated Dupuytren’s tissue 
were analysed by immuno-histochemistry, and summarised in Table 6. Counts 
were made from five fields (x 25 magnification) from comparative areas of the 
nodule periphery. Three consecutive slide sections were counted for each patient 
sample.
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3.4
Flow Cvtometrv Aaalvsis for Annexin V Binding of Cells from Dupuvtren’s 
Tissue Cultures. Palmar Fascia Tissue Cultures and Fascia Lata Tissue 
Cultures
Steroids produced different effects on Annexin V binding for the three groups of 
cells analysed by flow cytometry. These groups were cells from (1) Dupuytren’s 
cell cultures, from (2) palmar fascia cell cultures and from (3) fascia lata 
cultures. In the first group of 6 separate Dupuytren’s cell cultures there was an 
increase in the percentage of cells purely binding Annexin V from 1.7% to 18% 
and this was statistically significant (p<0.02) (Table 7). In the second group of 
palmar fascia cells, the 6 individual cultures had been added together into 2 
groups in order to give sufficient cells for FACS analysis. Following the addition 
of steroid, Annexin V binding altered from 4.3% to 3.9% (Table 8). In the last 
group of fascia lata cells, steroid added to the cultures altered average Annexin V 
binding from 4.3% to 5.3% (Table 9). Thus, only the Dupuytren’s cells had a 
statistically significant increase in Annexin V binding on the addition of steroid 
(Table 7).
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TABLE ?
Flow Cvtometrv for Annexin V in Cell Cultures from Dupuvtren’s Tissue. 
With and Without The Addition of Steroid to The Culture Medium 
Percentage of Annexin V positively staining cells in gated area
DÜPUYTRER 
CELL CULTURES
CONTROL
%
STEROID
%
1A U 8»
IB Z8 '
2A OZ 1JI
« 2B 11.#
n MiiiMHFrrrir
AVERAGE
+/-1 Standard Deviation
3.9
+/-3.1
*17.3
+M1.0
Mann-Whitney U test Level of 
Significance
* p<0.002
The percentage of cultured Dupuytren’s cells expressing purely Annexin V 
binding on flow cytometry analysis. Each culture was independently reassessed 
by analysing a further sample (A and B). The effect o f the addition o f a solution 
with solu-medrone (10'  ^M) on Annexin V binding is expressed in the second
163
column. In all cases, there was an increase in Annexin V binding and this was 
statistically significant as analysed by Mann-Whitney U test.
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Figure 31
Illustrative Figures Of Annexin V Binding Bv Flow Cvtometrv For Cells From 
Pre-Operativelv Untreated Dupuvtren’s Tissue Cultures. With And Without The 
Addition Of Steroid To The Culture Medium
Typical Flow cytometry analysis of Dupuytren’s sample. The left two graphs 
demonstrate 2 samples of pre-operatively untreated Dupuytren’s cells. The right 
two graphs demonstrate the same cells samples treated with solu-medrone 10'  ^M 
added to the culture medium. Pure Annexin V binding is measured in the lower 
right quadiant as in the superior graphs. Where the pattern for cellular staining did 
not lend itself for quadrant division, the area was gated for the Annexin V binding 
cells as seen in the lower graphs (R3), and the reading of pure Annexin V binding 
compared. As can be seen there was an increase in Annexin V binding after the 
addition of steroid.
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TABLE 8
Flow Cvtometrv for Annexin V in Cell Cultures from Palmar Fascia Tissue. 
With and Without The Addition of Steroid to The Culture Medium
Percentage of Annexin V positively staining cells in gated area
PALMXR FASCIA - c o w m o t teR O fD
CELL CULTURES % %
1 M  ^  3.1
2
AVERAGE 6.25 4.75
The percentage o f cultured Palmar Fascia cells expressing purely Annexin V 
binding on flow cytometry analysis. The effect o f the addition of a solution with 
solu-medrone (10'  ^M) on Annexin V binding by individual cells is expressed in 
the second column.
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Figure 32
Illustrative Figures Of Amiexin V Binding Bv Flow Cvtometrv For Cells From 
Palmar Fascia Tissue Cultures. With And Without The Addition Of Steroid To 
The Culture Medium
Typical Flow cytometiy analysis of pooled samples for palmar fascia cultures. 
The left two graphs demonstrate 2 samples of untreated Palmar Fascia cells. The 
right two graphs demonstrate the same cells samples treated with solu-medrone 
10'  ^M added to the culture medium. Pure Annexin V binding is measured by 
gating for these cells (R3 in upper graphs and R2 in lower graphs). There was no 
consistent change in the Annexin V binding.
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TABLE 9
Flow Cvtometrv for Annexin V in Cell Cultures from Fascia Lata Tissue. 
With and Without The Addition of Steroid to The Culture Medium
Percentage of Annexin V positively staining cells in gated area
............
..... ..
AVERAGE 9.4 4.5
The percentage o f cultured Fascia Lata cells expressing purely Annexin V 
binding on flow cytometry analysis. The effect o f the addition o f a solution with 
solu-medrone (10'  ^M) on Annexin V binding by individual cells is expressed in 
the second column.
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Figure 33
Illustrative Figures Of Annexin V Binding Bv Flow Cvtometrv For Cells From 
Fascia Lata Tissue Cultures. With And Without The Addition Of Steroid To The 
Culture Medium
Typical Flow cytometiy analysis of Fascia lata samples. The left two graphs 
demonstrate 2 samples of untreated Tensor Fascia Lata cells. The right two graphs 
demonstrate the same cells samples treated with solu-medrone 10'  ^M added to the 
culture medium. Pure Annexin V binding is measured by gating for these cells 
(R3 area in graphs). There was no consistent change in the Annexin V binding.
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CHAPTER 4 
DISCUSSION
4.1 Dupuvtren*s Disease - A chronic inflammatory condition
4.2 Effect of steroids on transendotheiial migration 
and extracellular matrix constitution
4.3 Steroid Induced Auoptosis in Dupuvtren's disease
173
4.1
Pupuvtren*s Disease - A Chronic Inflammatory Condition
From these immuno-histology results looking at the pro-inflammatoiy cytokines, 
it is apparent that the mononuclear cells, endothelium and nodular fibroblasts in 
Dupuytren’s disease express ÏL-1, TNF-alpha and IL-8. A possible hypothesis is 
that if this IL-8 production is a sustained production, then it will lead to a chronic 
inflammatory cell infiltration of the palmar fascia tissues by virtue of its 
leukocyte chemoattractant and angiogenesis promoting properties. The 
fibrogenic cytokines produced by both the inflammatory cells and the fibroblasts 
would lead to fibroblast proliferation and ultimately fibrosis and to the condition 
known as Dupuytren’s Disease.
Evidence to support this hypothesis can be based on the spectrum of clinical 
conditions associated with Dupuytren’s disease and on the biological effects of 
the associated growth factors. In all the medical disorders associated with 
Dupuytren’s disease, peripheral blood monocytes produce increased amounts of 
TNF-alpha or IL-1 (Table 10). These pro-inflammatoiy cytokines promote the 
adherence of circulating inflammatory cells to endothelium, facilitate their 
migration into the Dupuytrens tissues and may induce a complex cascade of 
cytokine interactions leading to fibroblast proliferation and ultimate fibrosis.
Trauma appears to be the only acute condition, which may be triggering the onset 
of Dupuytren’s contracture. This may be only in genetically susceptible 
individuals. Within a few months following a carpal tunnel decompression or
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Colles fracture Dupuytren’s nodules can appear. In this situation, after injury, the 
acute phase response will produce large numbers of activated monocytes and 
lymphocytes circulating through the microvessels of the palmar fascia. Factors 
that increased the endothelial stickiness for these inflammatory cells would 
increase their transmigration into the palmar fascial tissues. If the production of 
pro-inflammatory cytokines is increased, for whatever reason, then both the 
circulating inflammatoiy cells would be activated and the endothelium would 
increase adhesion molecule expression. In acute trauma the production of such 
pro-inflammatory cytokines as TNF-alpha and IL-1 will be greater than in 
chronic conditions, perhaps explaining the rapid onset here in those genetically 
susceptible patients.
Elevated circulating levels of pro-inflammatoiy cytokines are found in chronic 
conditions associated with Dupuytren’s contracture (Table 10). It may be 
theorised that people who develop Dupuytren’s contracture, have cells in their 
palmar tissue, which respond to these elevated cytokine levels by producing their 
own local inflammatory mediators in a sustained response and fail to switch off 
by the normal physiological feedback mechanisms. This would ensure the 
endothelium wall remained activated to attract in further inflammatory cells and 
refuel the cycle.
For example, in hepatic cirrhosis, associated with Dupuytren’s contracture, the 
peripheral blood monocytes produce increased amounts of TNF-alpha (McLain 
and Cohen, 1989), associated with further acute peaks with episodes of 
endotoxaemia, independent of sepsis (Bigatello et a l, 1987)
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Dupuytren’s disease was reported to develop within one month of immobilisation 
in bed for pulmonary tuberculosis (Hueston, 1991). During this phase of 
treatment the mycobacteria were being destroyed, and this has been shown to be 
associated with the peripheral blood monocytes producing increased amounts of 
TNF-alpha. (Ogawa et a l, 1991). The baseline of circulating TNF-alpha is also 
elevated in tuberculosis perhaps priming the system (Kaplan, 1994). TGF-beta 
production by blood monocytes from patients with active tuberculosis is also 
enhanced (Toossi et a l, 1995).
Spontaneous release of TNF-alpha and IL-1 from peripheral blood monocytes is 
much increased in HIV infection (Roux-Lombard et a l, 1989), particularly in the 
later clinical stages of Acquired Immunity Disorder Syndrome (AIDS), when the 
incidence of Dupuytren’s contracture is much increased. Increased soluble TNF 
receptor expression was noted by monocytes and CD8+ lymphocytes in HIV-1 
infected patients (Rautonen et a l, 1994; Kalinkovich et a l, 1995) and HIV-1 has 
been noted to induce TNF alpha and IL-1 gene expression in primary human 
macrophages independent of productive infection (Herbein et a l, 1994); 
macrophages more often stain positive for IL-1 in HIVpositive patients than in 
controls (Tyor et a l, 1993). HIV infection induced TNF alpha release can also 
stimulate arachidonic acid and subsequent PGE2 release from mononuclear 
phagocytes (Nokta et a l, 1995). HIV infected Kaposi sarcoma cells produce 
more IL-1 beta, IL-6 and bFGF (Huang et a l, 1993).
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In vitro, peripheral blood monocytes from patients with epilepsy, when 
stimulated produce significantly more IL-1 alpha and beta and IL-6 than 
peripheral blood monocytes from normal control patients. There was no 
statistical difference in this cytokine production between patients receiving anti­
epileptic drugs, though those treated with carbamazepine did have elevated IL-2 
production by the blood monocytes (Pacifici et a l, 1995).
An elevated Low Density Lipoprotein (LDL) level occurs in Diabetes Mellitus 
(DM), smoking and hyperproteinaemia. Peripheral blood moncytes are induced 
to produce IL-1 when there is an elevated level of minimally oxidised LDL 
(Cathartg^a/., 1985)
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Table 10
Clinical conditions associated with Dupuytren’s Disease where there is 
increased synthesis of pro-inflammatoiy cytokines by circulating peripheral 
blood mononuclear cells
Alcoholic Liver Disease TNF-alpha (McLain and Cohen D, 1989)
HIV TNF-alpha, IL-alpha (Roux-Lombard et
a l, 1989)
Chronic Pulmonary Disease IL-1 alpha TNF-alpha (Strieter et a l.
1990)
Tuberculosis TNF-alpha (Ogawa et a l, 1991)
Increased LDL IL-1 alpha (Cathcart et a l, 1985;
(Diabetes Mellitus, Smokers, Griffith a/., 1988)
Hyperlipoproteinaemia)
Epilepsy IL-1 alpha (Pacifici et al, 1995)
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Effect of Steroids
Steroids reduced the expression of pro-inflammatory cytokines by endothelial 
cells, fibroblasts, macrophages and lymphocytes. In addition to the effect on the 
pro-inflammatory cytokines IL-1 and TNF alpha, steroids reduced IL-8 
production. By reducing IL-8, there is a reduction in the chemoattractant gradient 
for inflammatory cells to undergo transendothelial migration.
Criticism could be made of the qualitative assessment of cytokine presence by 
immuno-histochemistry for these first experiments. However, this assessment has 
been used before in peer reviewed articles (Magro et a l, 1995) for assessing 
immimo-histochemisty sections. Ideally, automated digitalised assessment of 
antibody binding in these sections would have given more robust data for 
analysis but this was not available at this time.
Nevertheless, the reduction in general pro-inflammatory cytokine expression 
appeared substantial. This may be secondary to a reduction in the total number of 
inflammatory cells or due to less cytokine production by individual inflammatory 
cells or fibroblasts. The results demonstrate inflammatory cells are still present, 
so it is not the complete removal of such cells that is reducing the production of 
pro-inflammatory cytokines.
The discussion can be divided into the effect of steroids on the orchestration of 
inflammatoiy cells trans-endothelial migration mechanism and the subsequent 
extracellular matrix constitution, and that of direct apoptosis of the fibroblasts
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and inflammatory cells constituting Dupuytren’s nodules and involved in the 
process of fibrosis.
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4.2
Effect of steroids on transendothelial migration and extracellular matrix 
constitution
Fibrosis is a process involving mononuclear cells and lymphocyte regulation. 
Most clinically fibrosing conditions have been demonstrated histologically to 
contain macrophages, eosinophils or lymphocytes eg. systemic sclerosis (Kraling 
et a l, 1995), renal interstitial fibrosis (Eddy, 1995; Yamate et a l, 1995), 
sarcoidosis (Hunninghake, 1995), idiopathic pulmonary fibrosis (Xing et a l, 
1996; Groen et a l, 1994), reidel’s thyroiditis (Heufelder and Hay, 1995) 
retroperitoneal fibrosis (Hughes and Buckley, 1993; Menke et a l, 1996) and 
Dupuytren's disease (Baird et a l, 1993a), and some of these have had impressive 
clinical results after treatment with steroids.
It would appear that these inflammatory cells infiltrate sites of inflammation after 
triggering by chemotactic and activating mediators. This is followed by an 
escalation of cytokines that induce fibroblast and endothelial proliferation with 
the subsequent deposition of extracellular matrix. In the absence of inhibitory 
signals the continued production of these mediators sustains the connective tissue 
accumulation resulting in permanent alteration in tissue structure and fimction.
Dupuytren’s contracture is a chronic inflammatoiy disorder characterised by 
palmar nodules of proliferating fibroblasts, which eventually become 
incorporated into cords of mature scar tissue, producing finger contracture. 
Inflammatory cells have been found at the periphery of Dupuytren’s nodules
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(Baird, 1994; Sugden et a l, 1993; Andrews et a l, 1991). These appear to 
produce a number of potent growth factors and cytokines (Baird et a l, 1993b; 
Gonzalez et a l, 1992; Badalamente et a l, 1992), It may well be that it is this 
drive that stimulates Dupuytren’s myofibroblasts to express their contractile 
fibrosing phenotype (Baird, 1994). To prevent the accumulation of these 
initiating infiammmatory cells it is necessary to discover the pathway for their 
migration.
These results have shown that it would be possible for «4^1 carrying 
infiammmatory cells to adhere to Dupuytren’s nodule blood vessels and the 
peripheral nodular tissue as they express VCAM-1 molecules and the CSl site of 
fibronectin. The expression of and VCAM has also been studied in two 
cases of acute and late stage (fibrotic) sympathetic opthalmitis. In the acute 
stages (similar to the active periphery of Dupuytren’s nodules) there is also an 
increase in a4j51 and VCAM-1 expression and lymphocyte infiltration versus 
normal eyes. However in the later stages (equivalent perhaps to cord tissue) there 
is no significant increase in or VCAM versus normal iris cilary body and 
choroid (Kuppner et a l, 1993).
In many samples, the immunohistochemistry staining of CSl fibronectin 
appeared to have a surface pattern of distribution on the myofibroblasts as well 
as an extracellular distribution. The expression of fibronectin at the surface of 
myofibroblasts and in the rough endoplasmic reticulum and Golgi complex of 
myofibroblasts has been noted previously (Del Cacho et a l, 1993; Singer et a l, 
1984; Eyden, 1993). The surface fibronectin has been found to co-localise with
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actin fibres at regions surrounding the nucleus and form a fibronexus, 
representing an intracellular junction between myofibroblasts. In particular, it 
provides contact between myofibroblasts and the matrix that mediates continuity 
between intracellular contractile filaments and extracellular matrix proteins such 
as collagen (Singer, et a l, 1984; Eyden, 1993). The fact that the myofibrolasts in 
Dupuytren’s tissue have intense cell surface staining with antibody confirms the 
presence of a fibronectin fibril of a fibronexus. This has been previously 
demonstrated by electron microscopy (Tomasek and Haaksma, 1991).
In pulmonary fibrosis, there is again a chronic inflammatory disorder but with 
neutrophils involved in the early alveolitis. Nakoa, demonstrated increased E- 
selectin expression restricted to the honeycombing regions and that this co- 
localises with neutrophil distribution (Nakoa et a l, 1995). This suggested 
another mechanism for the accumulation of a subgroup of inflammatory cells 
involved in an active chronic inflammatory fibrotic disease.
Interestingly, post-irradiation lung injury demonstrates a release of cytokines 
after in vivo irradiation, which persists after exposure in some patients and 
initiates the cycle of chronic inflammatoiy events resulting in fibrosis (Rubin et 
a l, 1995). We have demonstrated TGF-beta has a similar distribution with CSl 
fibronectin in Dupuytren’s tissue. Ideally, dual staining would have been 
performed on sections to see if there was precise co-localisation. Also 
interesting, TGF-beta has enhanced expression in human lung granulomatous 
inflammation (Roman et a l, 1995) and sarcoid granuloma (Limper et a l, 1994) 
compared to normal lung tissue, and has been noted to co-localise with the aSpi
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integrin, (ligand for fibronectin) and alfiX integrin, (ligand for collagen) (Roman 
e ta l, 1995).
The advantage of Dupuytren’s tissue was its accessibility in large numbers and 
that it possesses the whole temporal and histological architecture of cells, 
cytokines and extracellular matrix in one specimen. Thus what we have 
demonstrated in Dupuytren’s disease is a reproducible mechanism for the 
accumulation of a subgroup of inflammatory cells in the Dupuytren’s nodule by 
their adhesion to the endothelial wall and extravasation into the nodule and it 
appears these cells may be a potential source of TGF-beta. If the differential 
expression of these integrins and adhesion molecules involved in inflammatoiy 
cell activation and adhesion can be altered then this would represent a therapeutic 
option (Figure 22a, b).
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Figure 34 (a)
The trans-endothelial migration of inflammatory cells expressing VLA4 integrin 
into the tissues necessitates binding to the VCAM-1 adhesion molecule or CSl 
sequence of fibronectin. The inflammatory cells in areas of high CSl fibronectin 
presence stimulate pro-inflammatory cytokine and growth factor production, such 
as TGF-beta 1 & 2.
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Figure 34 (b)
This process of trans-endothelial migration is influenced by many factors. One of 
these may be the down regulation of VCAM-1 expression by steroids. The 
subsequent decrease in inflammatory cell migration and activation by binding to 
extracellular matrix molecules, such as CSl sequence of fibronectin, will result in 
the reduction of pro-inflammatory cytokine synthesis and subsequent fibrosis.
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Steroids are already known to reduce VCAM-1 expression in cultured aortic cells 
(Aziz and Wakefield, 1996). We have demonstrated a massive reduction of 
VCAM-1 expression by Dupuytren’s endothelial cells in humans subsequent to 
hydrocortisone injection treatment. Steroids although reducing VCAM-1 
induction did not totally block CSl fibronectin production and therefore will still 
allow some cells expressing aAp\ to accumulate in the extracellular matrix. We 
had noted that some cells expressing aApi appeared to be elongated like 
fibroblasts. These cells were found to express Mac387 and CD68 markers 
suggesting them to be macrophages behaving like fibroblasts rather than a4^1 
expressing myofibroblasts.
The fact that TGF-beta production is not totally blocked by steroid injection is 
perhaps not surprising. The continued presence of «4^1 expressing inflammatory 
cells, with which TGF-beta is often closely localised, are a potential source of 
this potent cytokine. Also other cells than a4^1 expressing cells, Dupuytren's 
fibroblasts in particular, will produce TGF-beta 1 and 2 (Kloen et a l, 1995). The 
fact that steroids reduced TGF-beta presence agrees with a series of experiments 
where animal wounds given systemic glucocorticoids and there was a 
suppression of TGF-beta I and II (Frank et a l, 1996). As yet unpublished results 
by this department have shown that IL-1 alpha stimulated TGF-beta production 
by Dupuytren's cells in culture is reduced when methylpredisilone is added to the 
medium. Normal cultured skin cells showed no decline in baseline production of 
TGF-beta with the addition of methylprednisilone of the same concentration 
(Baird, Personal communication).
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The biological activity of TGF-beta is controlled by their persistence in the 
extracellular compartment as latent complexes. TGF-beta isoforms are non- 
covalently associated with a latency-associated peptide (LAP). LAP is required 
for efficient TGF-beta secretion, preventing TGF-beta binding to ubiquitous cell 
receptors, and maintaining its availability in a large extracellular reservoir that is 
readily accessed by activation. The latent TGF-beta is secreted by all cells and is 
abundant both in circulating forms and bound to the extracellular matrix. The 
mechanisms of regulation of activation of this latent form of TGF-beta are 
complex (Bonewald, 1999). A number of molecules are involved in this 
activation step. Anti-inflammatory molecules such as hydrocortisone inhibit 
TGF-beta by a mechanism that may include downregulation of transglutaminase 
expression (Gosiewska et a l, 1999). This may be one mechanism steroids inhibit 
TGF-beta activation in Dupuytren’s disease.
Given TGF-beta’s critical role in fibrosis this suggests further work is required to 
modulate its production and activation. The control of inflammatory cell 
migration and adherence may allow modulation of fibrosis. Other drugs already 
exist which block CSl fibronectin or u4/?l itself (Elices, 1995) and once these 
and drugs which bind to other implicated integrins reach clinical status further 
immuno-modulation of Dupuytren’s disease and fibrosing diseases in general 
may be possible in the future. Although it would be simplistic to suggest that 
aAp\ / VCAM-1 transendothelial migration is the sole pathway involved here, it 
nevertheless demonstrates how one pathway mechanism can be modulated in 
active chronic inflammatory conditions.
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4.3
Steroid-Induced Apoptosis in DttPttvtren’s disease
Chronic inflammation and the factors that regulate leukocyte survival in this 
environment are being actively investigated. Chronic inflammation recruits 
monocytes from the blood into the lesion where they, upon exposure to specific 
stimuli, differentiate into activated macrophages (Zembala, 1989). These 
macrophages have a role in exacerbation and resolution of chronic inflammation 
by phagocytosis and production of cytokines, arachidonic acid metabolites and 
reactive oxygen species (Zembala, 1989). In the resolution phase, in which 
healing occurs, the secretion of cytokines decreases and the number of 
inflammatory cells decreases, particularly monocytes. This is achieved without 
release of lysosomal enzymes from leukocytes and without further tissue damage 
and inflammation. The mechanisms involved in this are not fully determined but 
histological evidence suggests apoptosis (Savill et a l, 1990). Survival of 
leukocytes within a lesion appears to be associated with inflammation 
continuing. For example, rheumatoid arthritis has been theorised as being a T- 
cell-mediated disease, the primary defect being lack of apoptosis.
Dupuytren's contracture has been compared histologically to a sarcoma tumour 
and Azzarone found growth properties of the myofibroblasts derived from 
Dupuytren's nodules lay between normal fibroblasts and virus-transformed or 
sarcoma-derived fibroblasts (Azzarone et a l, 1983). Actual fibrosarcoma, as 
with all tumours, represents an imbalance between proliferation and apoptosis of 
cells. Interestingly, Kihara et al compared infantile fibrosarcoma, which often
191
undergo a benign course or may even undergo spontaneous regression, with the 
phenotypically similar adult fibrosarcoma that does not (Kihara et a l, 1996), 
They demonstrated infantile fibrosarcoma had a significantly enhanced apoptosis 
rate coupled with a lower proliferative index and suggested this was compatible 
with its benign course. Dupuytren’s contracture, although not a malignant 
tumour, represents a similar imbalance between particular subsets of cells within 
an inflammatory tissue.
Steroids are the most potent and effective agents in controlling inflammatoiy 
diseases (Barnes and Adcock, 1993). Clinically, steroid injections can induce 
Dupuytren’s nodule regression (Ketchum et a l, 1972) and histologically this 
appears to be by apoptosis (Meek et a l, 1998). Steroids may induce this 
apoptosis by a number of methods including the following.
Steroids and modification of cell adherence
Steroids have a multiplicity of effects on the underlying extracellular matrix 
affecting fibronectin and the balance of various binding sites. For example, 
steroids alter the distribution of fibronectin, or distribution, type and synthesis of 
collagen and if s binding properties. This work has demonstrated a down 
regulation of the fibronectin CS1 domain in Dupuytren's tissue after treatment 
with steroid and this may play a role in the rate of cellular apoptosis. There is 
also an increase of collagen type III over type I (Murrell et a l, 1989; Brinkley- 
Parsons et a l, 1981). The effect of steroids on this ratio and other matrix
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compounds is not precisely known nor how this would affect the binding of cells 
and their apoptosis rates.
In some cases binding may augment apoptosis depending on the cell type. A 
study of myeloid leukaemia cell line (M07E), which proliferate in response to 
human granulocyte/macrophage colony stimulating factor, was undertaken in 
relation to fibronectin regulation. Fibronectin induced growth suppression in the 
face of stimulation factors by causing apoptosis. Adding anti aSpl antibody but 
not anti aApl antibody could reverse this. In addition, fibronectin induced 
apoptosis was detected in other haemopoeitic cells expressing a5p\ but not in 
aSpi negative cells (Sugahara et a l, 1994). In this case the fibronectin aSp\ 
binding site may allow negative regulation.
The basement membrane extracellular matrix induces differentiation and 
suppresses apoptosis in mammaiy epithelial cells whereas cells lacking the 
basement membrane lose their differentiated phenotype and undergo apoptosis 
(Boudreau <3/., 1996).
Various different mechanisms may co-exist for controlling adherence of the 
monocytes, T cells and myofibroblasts apoptosis. These factors presumably 
apply in Dupuytren's tissue, controlling the rates of inflammatory cell apoptosis, 
and as steroids modify the matrix constitution, they alter the rate of apoptosis.
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Reduction in inflammatory cell load bv apoptosis
Steroids may cause cells to directly undergo apoptosis, alternatively the cells 
may secondarily undergo apoptosis due to a reduction in pro-inflammatory 
cytokine production
T cells
The majority of thymocytes are sensitive to the apoptosis inducing activity of 
glucocorticoids while the majority of mature peripheral T cells are resistant to it 
(Iwata, 1995). T cell specific growth factor IL-4 specifically rescues Tm  cells 
from steroid induced apoptosis (Zubiaga et a l, 1992) whereas IL-2 and IL-1 are 
ineffective in preventing apoptosis for these cells. However, IL-2 is the relevant 
rescue factor for glucocorticoid induced apoptosis of Thi cells (Zubiaga et al, 
1992). The induction of apoptosis appears to involve protein kinase activation as 
inhibition blocks the protection effect (Zubiaga et a l, 1992).
Dupuytren’s tissue contains elevated levels of IL-1, IL-2 and IL-4 (Baird et al, 
1993b), which are reduced after steroid injections. In addition, there is immuno- 
histochemical evidence of T cell apoptosis on injecting steroids. This may be due 
to the observed reduction in cytokine production or a direct effect. The T cell 
subgroups that are undergoing apoptosis require to be defined.
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Macrophages
A multitude of factors are known to affect macrophage apoptosis in normal 
physiological resolution of acute inflammation (Tidball and St Pierre, 1996), 
including nitric oxide (Shimaoka et a l, 1995; Messmer et a l, 1996), Bordetella 
pertussis (Khelef and Guiso, 1995), GM-CSF (Gelirmann, 1995) and MC-SF 
(Munn et a l, 1995) or exposure to IFN-y (Munn et a l, 1995). The data here has 
certainly demonstrated steroids induce macrophage apoptosis in Dupuytren’s 
tissue. Again, this would reduce the pro-inflammatory cytokine drive to the 
myofibroblasts and possibly contribute to apoptosis of various cells.
Mvofibroblasts
Growth factors play a role in controlling apoptosis of fibroblasts. Certainly 
dexamethasone inhibits IL-1 and TNF production by human lung fibroblasts 
without affecting IL-1 or TNF receptors (Monick et a l, 1994) and could induce 
self-apoptosis by this downregulation.
A parallel scenario may be seen in the microglia of brain tissue. Apoptosis of 
microglia is hypothesised as a mechanism of maintaining steady state conditions 
in vivo. Again, either downregulation of microglial mitogens and survival 
factors, or directly induced programmed cell death in the microglial cells could 
be theorised. Certain microgUal growth factors induce a mitogenic response, but 
withdrawal enhances rates of microglial cell death by apoptosis, as assessed by
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DNA fragmentation studies (Gehrman, 1995). This suggests a reduction in the 
concentration of mitogens is one mechanism at work to initiate fibroblast 
apoptosis.
The effect of steroids may still be partly a direct effect on the fibroblasts. 
Certainly a direct effect has been demonstrated on rat osteoclasts which 
underwent morphological changes resembling apoptosis after 2-4 hours of 
exposure to dexamethasone and corticosterone (Lutton et a l, 1996).
The cultures of the Dupuytren’s tissue may contain other cells than purely 
fibroblasts and this may be another criticism of the flow cytometry results. 
Further antibody labelling of the cultures would prove if there are any significant 
subgroups of cells other than myofibroblasts. Otherwise, the effect on 
myofibroblast apoptosis can still be attributed to a reduction in cytokine drive 
from other cells in the culture.
This study did demonstrate that the steroid drug depomedrone induced apoptosis 
in Dupuytren’s tissue. This has not been reported before. By understanding the 
factors controlling cell proliferation and apoptosis in this chronic inflammation, 
possible improved methods of treating such diseases may be attained. Other 
drugs too can influence apoptosis by modifying the adherence to extracellular 
matrix molecules or the production of specific pro-inflammatory cytokines.
These drugs may well prove to be highly effective treatments for chronic 
inflammatory disease in general.
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In summary, Dupuytren’s contracture is a disabling disease of hand function and 
the treatment of the established contracture is not without morbidity. In order to 
prevent the progressive contracture, it is necessary to understand its 
development.
Lastly, I suggest Dupuytren's disease lends itself as a reasonable model for 
chronic inflammation with its sustained inflammatory cell infiltrate and 
extracellular matrix synthesis. By understanding the factors controlling 
inflammatoiy cell trans-endothelial migration and subsequent stimulation of the 
extracellular matrix and fibroblast proliferation, with its regulation by apoptosis, 
improved methods of treating chronic inflammation in such diseases may be 
attained.
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